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Molecular biophysics
Molecular modeling and dynamicsPlasma membranes are complex entities common to all living cells. The basic principle of their organization
appears very simple, but they are actually of high complexity and represent very dynamic structures. The inter-
actions between bioactive molecules and lipids are important for numerous processes, from drug bioavailability
to viral fusion. The cellmembrane is a carefully balanced environment and any change inﬂicted upon its structure
by a bioactivemoleculemust be considered in conjunctionwith the overall effect that this may have on the func-
tion and integrity of the membrane. Conceptually, understanding themolecular mechanisms by which bioactive
molecules interact with cell membranes is of fundamental importance.
Lipid speciﬁcity is a key factor for the detailed understanding of the penetration and/or activity of lipid-
interacting molecules and of mechanisms of some diseases. Further investigation in that way should improve
drug discovery and development of membrane-active molecules in many domains such as health, plant
protection or microbiology.
In this review, we will present complementary biophysical approaches that can give information about lipid
speciﬁcity at a molecular point of view. Examples of application will be given for different molecule types,
from biomolecules to pharmacological drugs. A special emphasis is given to cyclic lipopeptides since they are
interestingmolecules in the scope of this review by combining a peptidicmoiety and a lipidic tail and by exerting
their activity via speciﬁc interactions with the plasma membrane.
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1.1. General concept
As compared to nucleic acids, responsible for the genetic informa-
tion and proteins, that perform most of the functional and enzymatic
tasks, lipids often appear as “Cinderella” in the biomolecules family,
being considered as just sitting there passively.
The basic principle of the organizationofmembranes looks very sim-
ple, formed by lipid bilayers where the polar headgroups are facing the
aqueous environment and the hydrocarbon tails facing the interior of
the bilayer, yet the details are surprisingly complex. Hence, plasma
membranes (PMs) are complex dynamic entities which delimit the
cell from its environment. They are the point of exchangewith adjoining
cells, and between the cell and the external medium. They are the pri-
mary place where signal recognition and transduction into intracellular
responses for nutritional uptake, environmental responses, and devel-
opmental signalling occur [1,2]. Over years, it has become increasingly
clear that if they are laterally ﬂuid, they also can adopt a fascinating
range of spatial organizations like the formation of transient local or-
dered clusters which are biologically important for several functional
states of membrane proteins [2].
The cell membrane is a carefully balanced environment and any
change inﬂicted upon its structure by a bioactive molecule must be
considered in conjunction with the overall effect that it may have onTable 1
Lipid composition (in molar %) of different cell membranes in eukaryotic or prokaryotic organ
Lipids Eukaryotic cells
Human
erythrocyte
Human alveolar
macrophage
Rat
liver
A. thaliana leave S
PC 16 30 25 17 2
PE 15 21 12 18 1
PS 7 21 2 3 3
PG 4
CL ~
PI 0.5 4 5 9
PA 1 5
SLa 14 (SM) 7 (SM) 13 7 (GIPCa) 1
Sterola 46 (Chol) 8 (Chol) 43 (Chol) 46 (sitosterol) 3
Others 0.5 13 1
Ref [5,6] [7] [8] [1,10,11] [
PC: phosphatidylcholine, PE: phosphatidylethanolamine, PS: phosphatidylserine, PG: pho
sphingolipid, SM: sphingomyelin, GIPC: glycosyl inositol phosphorylceramides, MIPC: mannos
a The most abundant lipid of these categories is indicated in brackets.the function and integrity of the membrane [3]. Understanding the
mechanism at themolecular level bywhich bioactivemolecules interact
with cell membranes is therefore of fundamental importance.1.2. Plasma membrane composition
PMs are composed by three main classes of lipids: glycerolipids
(mainly phospholipids—PL), sphingolipids and sterols [2,4]. However,
between species or cell types within a species, the lipid composition
of PM can show a high degree of diversity; Table 1 illustrates this
complexity.
In eukaryotic cells, the major structural lipids are glycerophospho-
lipids, such as phosphatidylcholine (PC), phospatidylethanolamine
(PE), phosphatidylserine (PS) and phosphatidic acid (PA) [5–8]. Their
hydrophobic tails, with chain length varying mostly from 14 to 22 car-
bons are either satured or cis-unsaturated. PC is the most abundant, ac-
counting for more than 50% of PL [9]. The backbone of sphingolipids is
constituted by a ceramide with saturated or trans-unsaturated hydro-
phobic chains. In mammalian cells, sphingomyelin (SM) and glyco-
sphingolipids are the most abundant. Concerning sterols, cholesterol
(Chol) is predominating in mammals and has a preferential interaction
with sphingolipids, forming the so-called rafts domains (see below).
It is worth noting that the variation in headgroups and aliphatic
chains permits the existence of more than a thousand different lipids.isms.
Prokaryotic cells
. cerevisiae B. megaterium
Gram+
S. aureus
Gram+
P. aeruginosa
Gram−
E. coli
Gram−
5
0 73 60 82
Traces
27 58 21 6
2 42 11 12
0–20 (MIPC)
0–40 (Ergosterol)
13,15,17] [8] [19] [19] [19]
sphatidylglycerol, CL: cardiolipin, PI: phosphatidylinositol, PA: Phosphatidic acid, SL:
yl inositol phosphorylceramides.
Fig. 1. Schematic representation of membrane models described in the text: (A) lipid
monolayer, (B) supported lipid bilayer, (C) liposome.
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enriched in sterols (sitosterol and stigmasterol mainly) and sphingo-
lipids [1,10,11], which are packed at a higher density than glycerolipids
and resist tomechanical stress [1]. Although the results of lipid analyses
from several plant species are available in literature [12], a complete
characterization of plant PM is still lacking, more particularly con-
cerning the negatively charged glycosphingolipid (GIPC), speciﬁc to
plants and fungi [1,13,14]. In the case of fungi, GIPC with mannose,
called mannosyl inositol phosphorylceramides (MIPC) are the main
sphingolipids [13,15]. Other particularities of fungi PM is the presence
of ergosterol as sterol [16,17] and the wide variability in phospholipid
composition according to the culture medium supplementation [18].
Bacterial membranes, in contrast to eukaryotic membranes, present
a signiﬁcant higher population of negative intrinsic curvature lipids (PE
and cardiolipin) and negatively-charged lipids (phosphatidylglycerol
and cardiolipin) [8,19,20] and an absence of sterol [20]. As shown in
Table 1, diversity between Gram+ and Gram− bacteria is also very
important.
In parallel to the huge diversity in their global composition and lipid
asymmetry between the two leaﬂets, membrane lipids also occur in dif-
ferent lipid phases depending on their structure and environment (for a
review, see [2]). Globally, for the lamellar phases, three different
behaviors can be observed: (i) the liquid-crystalline or liquid-
disordered phase notably formed by glycerophospholipids with un-
saturated acyl chains, (ii) the solid gel phase due to SM-rich lipid
mixture; (iii) a third remarkable phase, liquid-ordered, is formed
by the association of sterol and bilayer-forming lipid. The latter is re-
lated to ‘raft’ domains, having a high order parameter and a high dif-
fusion coefﬁcient [2]. Since the 90s, the notion of lipid domains,
notably the raft domain model, has been put forward [21]. Those
detergent-insoluble glycolipid-enriched complexes or DIGs (or
DRM for detergent resistant membranes) are richer in sphingolipids
and Chol that are close-packed. It has been proposed that these lipid
domains anchor speciﬁc proteins involved in signalling and mem-
brane trafﬁcking [21,22], playing a role in the activity of those pro-
teins. The size and the thermodynamic stability of these entities are
not fully determined, but their dynamic nature has been stressed
[23,24]. Some evidence indicates that the clustering of lipid rafts
into more active signaling platforms depends upon interactions
with and dynamic rearrangement of the cytoskeleton [25]. While
the biological existence of such domain is still under debate, raft do-
mains have been suggested to be implied in a number of speciﬁc in-
teraction between biomolecules (peptides, proteins, drugs) and the
membrane [23].
Very recently, the existence of micrometric lipid domains (in com-
parison to rafts that are considered as nanometric structures) enriched
in glycerophospholipids and sphingolipids has also been visualized
using ﬂuorescent lipids, while still controversial in a biological context
[26,27].
1.3. Models of membranes
The existence of lipid domains, lipid asymmetry, coexistence of
phases and diversity in lipid composition are the reasons why mem-
branes are extremely intricate structures. The complexity of this system
is further increased by their association with proteins and carbo-
hydrates. This complexity makes the biophysical interactions with bio-
active molecules very difﬁcult to investigate in a ‘real’ situation [28].
Therefore, simpliﬁed artiﬁcial membrane systems, which mimic the
natural bilayer lipid membrane, have been developed [28,29].
Model membranes are systems in which the organization best
mimics the lipid arrangement found in natural plasma membranes.
Three systems arewidely used, i.e., lipidmonolayers, supported bilayers
and liposomes (Fig. 1).While each of these systems exhibits advantages
and disadvantages, they all mimic to a certain extent the lipid arrange-
ment of natural cell membranes (for review see [22]).Lipid monolayers provide a simple model considered as half the
bilayer of biological membranes. They can be used to study the ability
of compounds to penetrate into the outer leaﬂet of the membrane and
to characterize the interactions of the molecule of interest with lipids
[30,31]. They are formed at the air–water interface of a Langmuir trough
by spreading lipids of the membrane under consideration. Parameters
such as the nature and the packing of the spread molecules, the com-
position of the subphase (pH, ionic strength) and temperature can be
varied in a controlled way and without limitation [32].
Supported lipid bilayers (SLBs) are biomimetic model membranes
constituted of a ﬂat lipid bilayer supported onto a solid surface such as
mica, glass or silicon oxide wafers. These biomimetic systems typically
allow the investigation of interactions with lipid head groups but also
to predict the phase behavior and the molecular lateral organization of
biological membranes [28]. They can also be suitable to investigate
membrane-integral protein interactions in a functional manner [33].
They can be prepared by Langmuir–Blodgett technology, by fusion of
lipid vesicles or by surfactant depletion from micellar solutions com-
posed of a mixture of surfactants and phospholipids [34–36]. Since sev-
eral years, tethered or cushioned bilayers made up of a lipid bilayer
spaced from the solid surface by spacer molecules have been developed
in order to enhance the mobility of the lipids onto the support [33,37].
Supported lipid bilayer models can be prepared quite easily and are
much more stable than lipid vesicles. When SLBs are prepared by
Langmuir–Blodgett technology, the lipid asymmetry can be controlled
while it is not the casewhen using vesicularmodel systems. In addition,
as these membrane assemblies are conﬁned to the surface of a solid
support, they can be characterized much easier than free-ﬂoating
vesicles using a large variety of surface sensitive techniques such as
AFM [38–40], secondary ion mass spectrometry (SIMS) [41], ﬂuores-
cence microscopy [38], optical ellipsometry [42], quartz-crystal micro-
balance [43], X-ray reﬂectivity [44] and neutron reﬂectivity [45].
Lipid vesicles or liposomes are versatile biomimetic model mem-
branes commonly used for studying membrane phase behavior and
membrane processes such as membrane fusion, molecular recognition,
cell adhesion, membrane trafﬁcking and pore formation. These lipid as-
semblies enclose a small aqueous compartment and are produced from
the aqueous dispersion of membrane lipids (pure or in mixture).
Whereas lipid monolayers are constituted of only one lipid leaﬂet and
therefore do not reﬂect the complexity of biological membrane struc-
ture, lipid vesicles are composed of two leaﬂets, which are arranged in
a way that is similar to that of biological membranes. However, they
are metastable structures offering poor long-term stability [46–48]. De-
pending on the mode of preparation, liposomes could be multilamellar
or unilamellar (a single bilayer), and according to their size, are classi-
ﬁed as small unilamellar vesicles (SUV), large unilamellar vesicles
(LUV) or giant unilamellar vesicles (GUV) [49–52]. For a recent review
about their preparation modes, the reader can refer to [24].
Table 2
Commercially available model lipids for different species.
Species Glycerophospholipids Sphingolipids Sterols References
Plant PLPC GlcCera Sitosterol [80]
Fungi DOPC Phytosphingosineb Ergosterol [77,82]
POPE
Bacteria POPE [76]
POPG
CL
Mammalian POPC Sphingomyelin Cholesterol [78]
a C16 Glucosyl(ß) Ceramide (d18:1/16:0) D-glucosyl-ß-1,1′ N-palmitoyl-D-
erythro-sphingosine.
b (2S, 3S, 4R)-2-amino-1,3,4-octadecanetriol.
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Those models have been used to study the interaction of many mol-
ecules with the membrane. Among those molecules, peptides such as
cell penetrating peptides (CPPs), antimicrobial peptides (AMPs), viral
fusion peptides, lipopeptides or amphiphilic pharmacological drugs
have been widely studied. For the latter, since they usually have intra-
cellular targets, it is inevitable that theymust cross the PM (andpossibly
other intracellular bilayers). The use of biophysical approaches and
model membranes has shed light on a better understanding of drug/
lipid interaction, which is of critical importance for pharmacological sci-
ence (for a review, see [3,28]). A variety of such biophysical studies have
been published and we list below some of them in a non-exhaustive
way.
Withmodels as simple as DPPC/DOPC or DPPG/DOPCmonolayers or
liposomes, we have highlighted differences in lipid penetration and af-
ﬁnity of ﬂuoroquinolone antibiotics that are correlated to in vivo data,
such as cellular accumulation [53,54]. The effects of lipid composition
were also investigated for azithromycin (AZT) using simple membrane
models. The effects of AZT is lipid-dependent, inducing notably modiﬁ-
cations of elastic properties of DOPC [55], but not with SM and Chol
[56,57].
Liposomes as model membranes are also used to estimate drug efﬁ-
cacy, notably in the determination of partition coefﬁcient that measures
the amount of molecules entering into/through the biological mem-
brane [58]. Some studies using liposomes have also evidenced transport
mechanisms [59], or help understanding toxicity of some drugs [60,61].
The activity of antimicrobial peptides (AMPs) has also been widely
studied using model membranes. These peptides are a very promising
alternative to conventional antibiotics that suffer from increasing bacte-
rial resistance to their action. Recent publications [4,62,63] have focused
on those molecules, so we will not extensively review this area. Brieﬂy,
usingmodelmembranes and biophysical approaches, it was shown that
AMP afﬁnity for bacterial membrane is generally triggered by electro-
static interactions; AMPs are mostly positive cationic peptides that
interact preferentially with negatively charged lipids such as PG,
cardiolipin or LPS present in bacterial membranes [19,64,65]. AMP ac-
tivity also depends on the lipid structure (headgroup and acyl chains)
[4], and the presence of Chol is suggested to play a role in AMP selec-
tivity, while this is still under debate [66].
Models of membranes are also extensively used to characterize and
investigate the lipid interactions of nanosystems like liposomes [67,68],
nanoparticles [69,70], dendrimers [71–74] and also amphiphilic block
copolymers [75].
Most of the biophysical studies mentioned above or in recent re-
views decipher about the interaction of drugs, AMPs or other biomole-
cules with rather simple model of membranes, composed of two or
three different lipid types, few are discussing about lipid speciﬁcity, as
for AMPs, but rarely in a systematic manner.
However, lipid speciﬁcity should be an important factor for the un-
derstanding of mechanisms of lipid penetration and/or activity of the
interacting molecule or of mechanisms of some diseases, and is hence
of critical importance in life science. Further investigation in that way
should improve drug discovery and development of membrane-active
molecules in many domains such as health, plant protection or
microbiology.
In the following paragraphs, we will present practical information
and complementary biophysical approaches that can give information
about lipid speciﬁcity at a molecular point of view. Those methods are
applicable to any kind of molecules that can be puriﬁed and for which
3D structure is accessible in the PDB database or by models.
2. What kind of lipid to choose?
Since model membranes should be representative of natural mem-
branes, their reconstitution must reﬂect this “real” composition asbest, taking practical and experimental details into account. It is hence
important to soundly consider the choice of the lipids, of the model
(monolayer vs bilayer, type of liposome,… see above) and of the com-
plexity of the lipid mixture.
– Choice of lipids: This choice will be done according to different
criteria. The ﬁrst one consists in choosing an appropriate lipid
for the organism under consideration [76,77]. For example,
concerning model sterol, it is better to choose Chol for a study
with red bood cells [78,79], sitosterol when working with plants
[80,81], or ergosterol in the case of fungi species [82,83]. The sec-
ond criterion is the availability of the lipid. Some of them are
commercially available or could be easily extracted and puriﬁed
using well-known protocols, others are not. As an example,
plant sphingolipids are not commercially available and are very
difﬁcult to purify from plant cell extracts. In the same way, the
predominant ceramide in yeast is 4-hydroxysphinganine that is
not commercially available. In order to overcome this difﬁculty,
the use of available models as close as possible to the considered
lipid in terms of structure, charge, chain length and (un)satura-
tion should be considered. Table 2 gives the main commercially
available model lipids that can be used to prepare model mem-
branes for each organism.
– Choice of membrane model: each system has its advantages and
disadvantages and will be chosen according to the information
needed, considering the feasibility of the experiment. In order
to analyze the ﬁrst steps of the interaction of a bioactive molecule
with a membrane, the most suitable model will be Langmuir
monolayers whichmimic the external leaﬂet of themembrane bi-
layer [79,83–85]. Similarly, for the analysis of the insertion of a
membrane-active molecule within the membrane, liposomes or
supported bilayers will be preferred [79,86]. The limitation of
the models must also be considered: actually, it is impossible to
prepare liposomes containing only sterols.
– Choice of lipid mixture: The lipid composition of the model mem-
brane is one of the most important points. As expected, more the
composition of the model membrane is close to the reality, more
the experimental results will be biologically relevant. However,
increasing the complexity of the model membrane will in turn
render the biophysical observations difﬁcult to interpret. It is
therefore important to design carefully the experiments taking
into account this balance between complexity and feasibility.
Most of the studies using model membranes adopt generally a
step-by-step approach, bymodifying gradually the lipid composi-
tion, for example going from PC membranes to PC/sterol or to PC/
sphingolipid/sterol systems. In the literature, the most complex
systems contain generally three lipid types (PC, sphingolipid,
sterol).
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We have divided the biophysical methods into two groups (that are
non-exhaustive), depending on the kind of information you get:
1. “Global molecular”methods giving information on the global effects
of the molecule of interest on the lipids. These include (among
others): Langmuir monolayer technique, isothermal titration calo-
rimetry (ITC), ﬂuorescence spectroscopy and imaging, atomic force
microscopy (AFM), neutron reﬂectivity (NR), surface plasmon reso-
nance (SPR) or electron paramagnetic spectroscopy (EPR).
2. In the second group, we have considered techniques giving informa-
tion at the molecular/atomic level, that we call “molecular-speciﬁc”
techniques. In that group, we gathered infrared spectroscopy (FTIR
and PM-IRRAS), nuclear magnetic resonance (NMR) on lipids (31P,
2H, 13C NMR), secondary ion mass spectrometry (SIMS) and “in
silico” approaches.
All those methods are summarized in Fig. 2.Fig. 2. Schematic representation ofmost of thedifferent biophysical tools described in this review
classes of molecules, pictured at the centre of the ﬁgure, are under consideration: 1. cyclic lipo
peptide interacting with DPPE in the middle, 3. pharmacological drugs such as azithromycin (r
(blue atoms: nitrogen; grey atoms: carbon; red atoms: oxygen). Biophysical techniques are con
membranes (Langmuir trough, ﬂuorescence, ITC, NR, AFM), the other methods giving informa
ﬁgure, one example is giving for eachmethod: Langmuir trough assays represent the penetratio
surface pressure (Πi) (unpublished results). Fluorescence experiments show the effect of Aβ29-
the presence of increasing peptide:lipid ratio (adapted from [337]). ITC proﬁles are obtained
xylopyranoside (unpublished results). NR proﬁles are recorded 3 h after the injection of 20 μM
results). AFM topography image [z-range 10 nm] is obtained for mixed monolayers prepared a
in the images correspond to higher height. Adapted from Eeman et al. [146]. IR spectra re
101.3 MHz of multilamellar vesicles made of PC:PE:PI:PS:SM:Chol in the presence of Aβ29-42
23 and 31 peptides in model membrane with coexisting ﬂuid phases made of DPPC, DOPC and3.1. “Global molecular” biophysical techniques
3.1.1. Langmuir trough
The Langmuir trough technique applied on monolayer model at an
air–water interface has been extensively used since the beginning of
the 20th century [87] for characterizing lipid–lipid, protein–lipid or
drug–lipid interactions at amicrometric level.More recently, the combi-
nation of Langmuir trough with highly sensitive techniques like atomic
force microscopy (AFM), polarization modulated infrared reﬂection ad-
sorption spectroscopy (PM-IRRAS), Brewster angle microscopy (BAM),
ﬂuorescence microscopy, ellipsometry, nonlinear optical spectroscopy,
synchrotron basedX-ray scattering techniques has emerged as a power-
ful tool for visualizing lateral segregation and for obtaining structural in-
formation in phase-separated lipid monolayers at both micrometer and
nanometer scales [88]. Combination of two or more complementary
techniquesmakes the Langmuir technique oneof themost suitable plat-
form for learning about the mechanism occurring at the cell surface
[89,90].and used to study speciﬁc interaction between lipids and bioactivemolecules. Threemain
peptides represented left by surfactin in interaction with POPC, 2. peptides like SIV tilted
ight) associated to DOPC. The molecules are CPK-represented and phospholipids as sticks
sidered here as two groups: one group describing global effects of bioactive molecules on
tion at the molecular (atomic) level (NMR, IR spectroscopy, molecular modeling). In this
n kinetics of 1-18-bis-octadec-9-enyl-α-L-rhamnopyranoside into DMPC at different initial
42 tilted peptide on fusion of lipidic phases of liposomes (lipidic ﬂuorescent probe: R18) in
by successive injections of POPC vesicles into a solution of 1-18-bis-octadec-9-enyl-α-D-
fengycin on a d-P-h-O-PC bilayer in D2O.The line results from the ﬁtting (unpublished
t 0.25 fengycin molar ratio and ceramide. The image size is 15 μm × 15 μm. Lighter levels
present the Amide I band of mycosubtilin with or without lipids. 31P NMR spectra at
(adapted from Mingeot-Leclercq et al. [337] JCP). MD simulations of the sorting of WALP
Chol. Adapted from Schäfer et al., [313].
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mation can be performed with the Langmuir trough technique.
The ﬁrst one is the basic compression isotherm assay which is a plot
of the changes in surface pressure that occur when reducing under a
pseudo-equilibrium condition the area occupied by insolublemolecules
spread at the air–liquid interface [88]. It gives information about mono-
layer formation,molecular area, monolayer phases, monolayer stability,
two-dimensional compressibility and interaction of species from the
subphase with the monolayer [88]. By performing a thermodynamic
analysis (calculation of the excess free energy of mixing and the free
energy of mixing), compression isotherm data give the evaluation of
the mixing behavior and hence the molecular interactions occurring
between molecules of different natures (i.e. drug-like molecule and a
phospholipid representative of a cellmembrane) spread at an air–liquid
interface [29,30].
The second type of measurement is the adsorption/penetration ex-
periments which aim to evaluate the ability of surface-active molecules
to adsorb at an air–liquid interface or to penetrate into a more or less
ordered lipid monolayer formed at the air–water interface. The increase
of surface pressure resulting from the interaction of the bioactive com-
pound with the lipid monolayer over time gives rise to the adsorption/
penetration kinetics [79,86,91,92]. By plotting the maximal surface
pressure increase observed at the steady state as a function of the initial
surface pressure of the lipid monolayer, the exclusion surface pressure
(Πe)—also called the maximum insertion pressure—as well as the syn-
ergy factor can be determined. These parameters are useful to deter-
mine the extent of bioactive molecules that bind to different lipid
monolayers [84].
The third way to work with the Langmuir trough technique is to
form a monolayer on the water surface with a subsequent transfer
onto a solid support to obtain lipid monolayer or bilayer representative
of a biomembrane [88,93–95]. The so-called Langmuir–Blodgett (LB)
technology gives the opportunity to apply techniques like AFM (see
below) not suitable for in situ analysis at the air–water interface.
3.1.2. Fluorescence spectroscopy and imaging
Fluorescence can be used in differentways to explore the interaction
between a biomolecule and liposomes. Several experiments can probe
the effect of the molecule on the membrane integrity. The modiﬁcation
of the environment of the ﬂuorescent probe following the interaction
with the bioactive molecule and the subsequent change in ﬂuorescence
intensity is indicative of membrane disruption, membrane fusion or ag-
gregation (for a review, see [96]). In the case of peptides, the intrinsic
ﬂuorescence of amino acids such Trp or Tyr can also be used to probe
membrane insertion [63,97,98].
To study leakage process, ﬂuorescence increase of self-quenched
carboxyﬂuorescein or calcein [99] encapsulated into lipid vesicles is
followed over time. Another technique consists in using ﬂuorescent
dye/quencher pairs such as ANTS (HPTS)/DPX, encapsulated in the
same liposome population [100]. When leakage occurs, concomitant
dequenching of ANTS (HPTS) is observed. For fusion and aggregation,
the intermixing of the lipid leaﬂets of the liposomes and that of aqueous
contents (for fusion only) can be observed. For the aqueous mixing,
ﬂuorescence quenching assays using ANTS/DPX [101] or Tb3+/DPA
[102] pairs are usually carried out. In this case, the ﬂuorescent dye and
the quencher are encapsulated into two different liposome populations.
Mixing of the aqueous compartments induces a ﬂuorescence decrease.
For the lipid mixing assays, dequenching or FRET (Forster Resonance
Energy Transfer) assays are used [103,104]. The latter provides a mea-
sure of the average distance between donor and acceptor ﬂuorescent
molecules, the ﬂuorescence energy emitted by the donor molecule
being transferred to the acceptor molecule if both molecules are close
enough (typically 1 b d b 10 nm) [105]. The two ﬂuorescent probes,
for example NBD-PE (donor) and Rh-PE (acceptor), are incorporated
into one liposome population and mixed to non-labelled vesicles.
When lipid mixing occurs, the dilution of the dyes decreases the FRETefﬁciency. Variation of this method is also suitable to detect the mixing
of the liposome inner monolayers [96]. Another method consists in la-
belling the lipid phase with R18, a lipophilic ﬂuorescent probe, at a
selfquenched concentration. Dilution of the probe due to fusion/aggre-
gation induces an increase of the dye ﬂuorescence [106].
By modifying the lipid composition, the global inﬂuence of one
speciﬁc lipid can be studied. We have notably shown the inﬂuence
of PE on the membrane fusion and disruption induced by tilted pep-
tides from viruses but not for tilted peptides involved in the interac-
tion with bacterial or mitochondrial membranes, that are more
inﬂuenced by acidic PL [107]. Fluorescent lipid-like probes further
allow the visualization of lateral structures of membranes. Lipid
domain formation can notably be visualized by probes able to specif-
ically label lipid phase. The well-known LAURDAN [108] displays
unique properties when inserted into membranes, i.e. it distributes
equally into ordered and disordered-like lipid phases but shows a
phase-dependent emission spectral shift, bluish in the ordered
phase and greenish in the disordered one [109,110]. It means that
it can give information directly from ﬂuorescent images by using
the proper set of emission ﬁlters. Other probes such as di-4-
ANEPPDHQ [111] or newly designed probes [112] able to measure
the degree of membrane order in artiﬁcial liposomes as well as in
living cells are also useful tools to quantify lipid order.
Other probes such as TR-DPPE (Texas-red dipalmitoylphospha-
tidylethanolamine) and NBD-DPPE (N-7-nitro-2-1-3-benzoxadiazol-4-
yl dipalmitoylphosphatidylethanolamine) partition respectively into
Ld and Lo phases [113]. Fluorescent sterols like dehydroergosterol
(DHE) can also be used to assess the importance of sterols in domain
formation [114,115]. These probes have been very recently used in sim-
ple binary DMPC/chol liposomes to demonstrate that α-hederin, a mol-
ecule from the saponin family, is able to have a speciﬁc interaction with
sterol and to induce lipid domain formation, in contrast to its aglycone
homolog, hederagenin [116].
BOPIDY (boron dipyrromethen) ﬂuorescent lipid analogs of
sphingolipids or PC have also recently been used to visualize
micrometric domains [26,27].3.1.3. Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) measures the heat released or
adsorbedwhen two interacting components are brought together in the
same environment and initiate a reaction. One binding partner is titrat-
ed into a solution containing the other partner at a constant tempera-
ture [117,118]. The changes in heat energy are recorded over time and
allow the evaluation of enthalpy changes due to the interaction be-
tween titrated and titrating solutions. This technique provides a com-
plete thermodynamic description of binding processes [119].
ITC has a large panel of pharmaceutical applications and in the ﬁeld
of biological membranes. This technique is a high-sensitivity method
suitable to provide a complete thermodynamic characterization of
an interaction at equilibrium conditions (e.g. interaction between
receptor–ligand, enzyme–substrate, antibody–antigen, cell–ligand,
drug–DNA…), without requiring a speciﬁc labelling [120].
In theﬁeld of biologicalmembranes, ITC is themethodof reference for
studying interactions between a bioactive molecule (surfactant/peptide/
protein) and model lipid membranes (vesicles or micelles) [121–124].
Different processes such as membrane formation, membrane binding,
peptide aggregation at the membrane surface, peptide conformational
change, membrane partitioning, and membrane solubilization can be
investigated using ITC. Parameters like binding afﬁnities, binding en-
thalpies, and binding stoechiometries as well as relevant concentrations
such as critical concentrations for the onset and end ofmembrane solubi-
lization can be determined [118]. These data can be used to provide valu-
able insight into the origin and nature (electrostatic or hydrophobic) of
bioactivemolecule–membrane interactions and the factors that inﬂuence
them.
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with a particular lipid [120,125,126] or a speciﬁc physical structure or
organization of the lipid bilayer [127] can be highlighted.
This calorimetric technique is also a convenient tool for determining
the critical concentration (CMC) at which surfactant micelles are
formed and the corresponding heat of micelle formation.
3.1.4. Atomic force microscopy
The atomic force microscopy (AFM) belongs to the local probe mi-
croscopy methods. The local probe (usually an oxide-sharpened
microfabricated Si3N4 tip) interacts directly with the sample surface.
Themeasurement is based on the sensing of interaction forces between
the tip and the surface via the electronic clouds of their external atoms.
A complete description of the technical aspect of AFM can be found in
[128].
AFM can operate in different modes, which differ mainly in the way
the tip ismoving over the sample, in order to visualize surface structures
and lateral organization (contact or tapping mode) or to study intra-
and intermolecular forces (force spectroscopy) [129–131,130,131].
The lateral resolution is in the nanometer range and the vertical resolu-
tion is around 0.1 Å [132]. AFM can be performed in aqueous solutions
making it suitable to study biological samples under physiological con-
ditions [131,132]. Nevertheless, the technique requires attaching the
sample onto a solid support which can limit the degree of freedom of
the molecules [133]. Tethered lipid bilayers [134] and bilayers on
holes [135] can overcome this problem but are still under development.
Since its invention in 1986 [136], AFMhas been largely used for pro-
viding three-dimensional images of single molecules (e.g. proteins,
DNA, RNA…) adsorbed on surfaces of two-dimensional protein crystals,
of living cells and for studying the lateral organization of supported lipid
membranes with a nanometer resolution [137–139]. Besides, this tech-
nology has been shown to be very useful for probing quantitatively
physical properties such as surface forces, surface charge and hydropho-
bicity, for measuring inter- and intramolecular interactions, as well as
for molecular recognition studies with speciﬁc chemical probes or
probes bearing biologically active molecule [140–144]. In the ﬁeld of
biomembranes, this technique is a powerful tool to observe phase-
separated domains of supported lipid bilayers on the micro and
nanoscales, and to monitor membrane remodeling and alteration
upon interaction with exogenous agents like solvents, (lipo)peptides,
proteins, detergents and antibiotics. The reader can refer to references
[133] and [145] for some examples.
AFM has also been largely exploited to obtain information about the
lateral organization of phase-separated lipid monolayers containing a
bioactive molecule [146,147].
Real-time imaging of bilayer formation and of interactions of bio-
active molecules with model lipid membranes have been performed
[39,57,148–152]. Recent progresses in AFM technique and set-up like
the high-speed AFM [153] and the continuous ﬂow AFM set-up [154]
offer promising perspectives in terms of rapid biological molecular
processes monitoring.
AFM has extensively been used to study the lipid selectivity of
molecules interacting with biological membranes. Although AFM is
not yet suitable for single-lipid mapping [155], the technique is useful
to determine the preferential binding site/lipid phase of exogenous
agents [57,138,156–161]. By varying the composition of the supported
lipid bilayers, it was observed for example that azithromycin perturbs
more strongly DPPC domains than SM or SM-Chol domains [57]. SIV
tilted peptide has also been shown to induce a preferential destabiliza-
tion of DPPC domains by forming nanoholes [138] while cyclosporine A
targets SM lipid [156].
3.1.5. Neutron reﬂectivity
Specular neutron reﬂectivity (NR) is a method of choice to provide
information on average structure and composition of ultra-thin ﬁlmlayered systems along the direction perpendicular to the interface
down to a nanometric scale (~2 nm) [162–164].
The principle is based on neutron scattering from materials by
interacting with the nucleus of the atoms [162]. The sensitivity of neu-
tron reﬂection to the layer structure depends on the contrast in neutron
refractive indexes of the layer components and the surrounding media,
which can be achieved by the contrast variation method and/or the use
of perdeuterated components [165]. The structural parameters (thick-
ness, surface coverage, refractive index) of the layers are derived from
variation in reﬂected intensity as a function of the wave vector (related
to the angle of incidence and the neutron beam wavelength) [166]. As
for AFM, the sample has to be supported on a planar substrate, which
can be a limitation for some sample analysis.
Since a decade, NR has shown its great potential for life science stud-
ies and more particularly for characterizing biomimicking membranes
and for probing their interaction with various biological molecules.
This method has already been applied for quantifying the presence
and vertical location of small amounts of exogeneous molecules within
a supported phospholipid bilayer and for observing their effects on the
bilayer in terms of thickness and roughness [166–168]. By varying bilay-
er composition, some speciﬁc aspects of the interaction can be
highlighted. As an example, in the case of Antennapedia homeodomain,
it has been shown by NR that its vertical repartitionwithin the bilayer is
dependent on the phospholipid charge [167]. Another example is the
phospholipase A2 which penetrates into the bilayer in increasing
order for DOPC, POPC and DPPC [166].
3.1.6. Surface plasmon resonance
Surface plasmon resonance (SPR) is a surface sensitive technique
powerful for monitoring in real-time afﬁnity, selectivity and kinetics
of biomolecular interactions without requirement of a speciﬁc label
[169,170].
SPR occurs at the boundary of two materials of different dielectric
functions [171], e.g. glass covered by a thin metal (typically gold) ﬁlm
and air or water. A p-polarized light is emitted by the light source,
reﬂected on the gold-coated sensor surface and detected by a diode
array detector. Typically, to study the interaction of a biomolecule
with a biomimetic membrane, a lipid monolayer or bilayer is immo-
bilized onto the gold layer and the biomolecule is injected over the sur-
face in a continuous ﬂow. If it adsorbs onto the biomembrane, changes
of the incidence angle due to refractive index modiﬁcation is observed
over time (Hall et al. [107]). From this sensorgram, binding events can
be visualized and kinetics of the interaction can be calculated. Besides
monitoring in real-time and use of free-label molecules, another main
advantage of the SPR technique is the high throughput of samples that
can be performed.
This technique has been largely used to study the membrane-
binding properties of proteins aiming at determining their lipid speciﬁc-
ity [169,172,173]. Itwas also applied to investigate the direct interaction
of antimicrobial peptideswithmodelmembrane systems to gain insight
into their mechanism of action [170,174]. It can, for example, detect
multiple steps of the membrane-binding process. It is also a powerful
tool to analyze ligand binding by integral proteins supported into a
lipid ﬁlm [171]. To our knowledge, this technique has been applied to
study themembrane interaction of bioactive small molecules like cyclic
peptides [175]; however, it is little used for the study of other biomole-
cules andwas never applied to lipopeptides or glycolipid biosurfactants.
3.1.7. Electron paramagnetic resonance spectroscopy
Electron paramagnetic resonance spectroscopy (EPR) is a spectro-
scopic technique that detects species that have unpaired electrons. For
the study of exogenous molecules–membrane interactions, different
variants of the technique (continuous wave EPR, electron spin echo
envelope modulation and double electron–electron resonance) can be
combined to obtain information on ordering, mobility and polarity of
phospholipids and mobility of exogenous agent within the membrane
Table 3B
Amide I band frequencies and assignment to secondary structures for a peptide (protein)
in deuterated water [196].
Wavenumber (cm−1) Secondary structure
1637–1624 Beta sheet
1644–1641 310 helix
1649–1641 Random coil and turns
1657–1649 Alpha helix
1671–1650 Turns
1690–1675 Beta Sheet
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compounds (exogenous agent and/or phospholipid labelled with
nitroxide for example) and deuterated phospholipids and water. More-
over, by using spin-labelled phospholipid with the spin-label attached
at different positions along the lipid, it is possible to probe membrane
packing at different depths. With this technique, we can also access to
information about the insertion depth, orientation and aggregation
state of the exogenous molecule within the membrane.
EPR technique has been applied to study the effect of the presence of
surfactants [177], of lipopeptides [178], of drugs like clomipramine
[179] and of dendrimers [180] on the structure of lipid bilayers or bio-
logical stratum corneummembrane [181,182]. It was also used to deter-
mine the location and dynamics of basic peptides [183] and to study
lipid nanodomain formation [184,185].
Other techniques like ellipsometry [161,186–190], quartz cristal mi-
crobalance with dissipation (QCM-D) [43], X-ray reﬂectivity [191–193]
can also be useful to obtain average information about speciﬁc interac-
tion between bioactivemolecule and biomimickingmembranes, but are
not further discussed in this review.
3.2. “Molecular-speciﬁc” biophysical approaches
3.2.1. Infrared spectroscopy
Infrared (IR) spectroscopy is a well-establishedmethod to study the
interactions between lipids and bioactive molecules that provide rele-
vant information at the molecular level. Since excellent papers or book
chapters presenting a detailed view of the IR techniques have been pub-
lished [194–198], we will focus exclusively on the use of IR techniques
for analyzing lipid speciﬁcity in the interaction between molecules of
interest and membranes. In the IR methods, different membrane sys-
tems can be used, such as liposomes (FTIR-ATR) or Langmuir mono-
layers (IRRAS or PM-IRRAS). In general, model membranes made of
one or two different types of lipids have been used. Usually, the spectra
of model membranes are measured alone and in the presence of the
membrane-active molecule.
Three principal regions are analyzed in the IR spectra:
• 3000–2800 cm−1: This region corresponds to the absorbance of the
alkyl chains derived mostly from the phospholipids [199,200].
• 1800–1400 cm−1: It corresponds to the absorbance of C_O ester and
phospholipid alkyl groups. In the case of a membrane-active protein
or peptide, the amide I and II bands also appear in this region [196,
199,200].
• 1300–1150 cm−1: This region corresponds mainly to the absorbance
of PL phosphate groups [199,200].
Tables 3A and 3B present a detailed view of different bands from re-
spectively DPPC, a phospholipid commonly used in model membranes
(Table 3A) and of the secondary structures found in peptides, based
on the absorbance of the amide I group (Table 3B).
As an example for the use of IR technique in lipid speciﬁcity, the
interactions of a small antiparasitic peptide named LGP (lipophilicTable 3A
Attribution of the IR bands for DPPC vesicles hydrated with deuterated water [199].
Wavenumber (cm−1) Attributions
2957 CH3 stretching, asymmetric
2924 CH2 stretching, asymmetric
2871 CH3 stretching, symmetric
2853 CH2 stretching, symmetric
1732 C_O stretching, ester
1467 CH2 bending
1380 CH3 bending, deformation, symmetric
1233 PO2− stretching, asymmetric
1171 C–O stretching, single bond
1159 C–C stretching, skeletal
1060 R–O–P–O–R
1082 PO2− stretching, symmetricglutathioine peptide), with different monolayers have been investigat-
ed using PM-IRRAS spectroscopy [201,202]. The monolayers made of
DPPG, DPPC, DODAB (dioctadecyldimethylammonium bromide, posi-
tively charged) and Chol or amixture of Chol and sphingomyelin to sim-
ulate lipid rafts, were used [201]. The authors suggest that the charge
state of the phospholipids has no inﬂuence on the peptide conformation
(which is unfolded) and orientation since the spectra obtained with
DPPG (negatively charged), DPPC (neutral) and DODAB monolayers
are similar. However, in the presence of Chol or “raft”monolayers, LPG
conformation shifted from an unfolded state to a folded turn structure,
concomitantly with an orientation parallel to the interface, suggesting
a lipid-speciﬁc interaction of the peptide.
For mycosubtilin, a natural antimicrobial lipopeptide acting on the
plasma membrane, many papers have been devoted to study its inter-
actions with different membrane systems, mostly using FTIR and PM-
IRRAS techniques [79,86,92,203–207]. When the peptide is inserted in
monolayers and liposomes constituted by DMPC, mycosubtilin is struc-
tured as γ-turn and interacts mainly with the lipid alkyl chains [86].
When DMPC/chol liposomes are used, signiﬁcant changes have been
observed [79]. The presence of Chol modiﬁes the secondary structure
of the lipopeptide from γ-turn to β-turn. Furthermore, thanks the ab-
sorbance of its phenol ring, the involvement of the tyrosyl residue in
the interactions with Chol-containing liposomes has been observed
[79]. This result is particularly important because a previous study
showed that the methylation or acetylation of the phenolic OH group
of Tyr residue abolishes the biological activities of mycosubtilin [208].
The authors concluded that the lipopeptide activity could bemodulated
by the interactions between the phenolic component of Tyr and sterols
present within the membrane. Sterol could therefore be the favored
partner of mycosubtilin, facilitating its incorporation in the membrane.
Contrarily to mycosubtilin, Chol does not seem to favor membrane
insertion of gramicidin S (GS), a powerful antimicrobial peptide with
bactericide and fungicide activities [209,210]. The effect of Chol on the
interactions between gramicidin S and liposomes has been analyzed
by FTIR spectroscopy, notably at the level of the amide I band of the
peptide [211]. Measurements were performed at 0 °C and 50 °C, with
DMPC liposomes containing or not Chol; at 0 °C, lipids are in gel state
whereas at 50 °C, they are in ﬂuid state. In the presence of DMPC lipo-
somes, when the temperature increases from 0 °C to 50 °C, gramicidin
can steadily penetrate into DMPC bilayer, as assessed by gradual confor-
mational changes of the peptide [212]. In the presence of Chol, the ab-
sorbance of GS amide I band is the same as that observed in buffer,
indicating that Chol induces the exclusion of gramicidin from the bilay-
er. At higher temperatures, GS molecules penetrate into the bilayer, but
to a lesser extent than into DMPC bilayers, underlying the “exclusion”
effect of Chol [211].
The analysis is also applicable to non peptidic molecules such as
glycolipids. Very recent studies were carried out in our laboratory on
the membrane properties of rhamnose-based glycolipids (RhBG). In
the presence of POPC liposomes, rhamnolipids interact mainly with
the phospholipid alkyl chains, C_O and phosphate groups. When
Chol is added, the interactions between the alkyl chains and RhBG are
lessmarked, suggesting again amodulating effect of Chol onmembrane
insertion (unpublished data).
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tive orientation of phospholipids and peptides, as it was done for the
SIV peptide and fragments derived from apoliproproteins [213,214].
In summary, IR spectroscopy is a powerful technique to study the
interactions of bioactive molecules with lipid systems at the molecular
level. Information on the conformation of themolecules and their orien-
tation as well as on the chemical groups involved within the inter-
actions can easily be obtained.
3.2.2. Nuclear magnetic resonance
Solution and solid-state NMR of lipids has been largely reviewed by
the group of E. Dufourc [215,216], so we will only give a brief descrip-
tion and mention the information we can get from this technique ap-
plied to lipids. Solution (for lipids dissolved in organic solvents) and
solid-state (for lipids in a hydrated membrane state) NMR is one of
the most powerful techniques to decipher structure and dynamics of
lipids. NMR relies on the presence of active atomic nuclei constituting
the lipids: 1H, 31P, 14N essentially; lipids can also be deuterated (2H)
or ﬂuorinated (19F).
The analysis of the chemical shift anisotropy Δσ in a 31P NMR spec-
trum is notably useful to determine speciﬁc interactions between phos-
pholipids and a bioactivemolecule at amolecular level. PLs organized in
bilayer give in a 31P spectrum a typical asymmetric shapewith a peak at
high ﬁeld and a shoulder at low ﬁeld. The difference between the two
peaks is called chemical shift anisotropy, Δσ. This parameter is particu-
larly sensitive to phase transition and temperature. In the case of amino-
glycoside antibiotics, the measurement of Δσ has suggested that these
molecules are able to decrease the motional freedom of the phosphate
groups of PL, and more particularly those of acidic lipids like phos-
phatidylinositol [217,218].
The analysis of the 14N in DMPC/DHPC bicelles can serve as probe for
changes in electrostatic environment of the polar headgroups of lipids,
by the study of the symmetry of the quadrupolar splitting of the 14N
nucleus of magnetically aligned bicelles. This was notably done for
curcumin, a natural compound interacting with membranes: it was
shown to be anchored to the bilayer by a hydrogen bond near the phos-
phate group, like Chol [219].
NMR can also help analyzing the structure of the molecule that
inserts into the lipids; this is widely used for peptides interacting with
modelmembrane systems [63,220–222]. On the other hand, NMR spec-
tral characteristics of a non peptidic biomolecule (such as antibiotics)
labelled with 15N for example, alone or in the presence of lipids can
also shed light on the molecular group involved in the interaction
[217].
3.2.3. Secondary ion mass spectrometry
Secondary ion mass spectrometry (SIMS) combines sample imaging
with the unambiguous identiﬁcation ofmolecules by theirmass [223]. A
primary ion beam is bombarded onto the sample which generates sec-
ondary ions with a very characteristic fragmentation pattern, allowing
the compounds to be identiﬁed [223,224]. It measures directly, without
partitioning of dye, themass of components or isotopically labelled frag-
ments from the components [225]. For a detailed description of the
technique, the reader can refer to the review of Boxer et al. [223].
This technique is still in its infancy concerning its application for
membrane lipid composition and distribution analysis because mass
spectra of membrane lipids are rich in acyl chain fragments, which are
largely identical for many phospholipids [224]. Other limitations are in-
sufﬁcient sensitivity, spatial resolution and preservation of the sample
without bulk water, as the analysis is done in high-vacuum condi-
tions [223]. SIMS technique has a great potential to image the distribu-
tion of speciﬁc molecules within complex biological samples and to
measure the amount of each molecule within a speciﬁed region of the
sample [223] but still needs instrumental development to fully achieve
these goals. A higher spatial resolution (down to 50 nm), a higher sen-
sitivity and a higher mass resolving power have been obtained by thedevelopment of new instruments like high-resolution dynamic SIMS
(NanoSIMS from CAMECA) [225]. By incorporating isotopically labelled
lipids into the lipids of interest, NanoSIMS can facilitate differentiation
of lipid signals and enhance their secondary ion yield [225]. Never-
theless, SIMS has a poorer spatial (lateral and vertical) resolution com-
paratively to AFM but provides more signiﬁcant molecular information
[223].
SIMS technique has already been applied to in situ analyses of lipids
in tissues or individual cells for biomedical purposes (for recent reviews
see [182,226]). It has also been used to analyze phase separation of lipid
on monolayer [227] or bilayer models [225,228,229] for acquiring new
insight into the molecular interactions involved in lipid organization
in membranes.
The distribution of exogenous agents like amphiphilic block copo-
lymers [230] or surfactant peptide [231] into a lipid monolayer has
already been explored by SIMS after Langmuir–Blodgett transfer onto
a solid support.
To date, only one study dealswith the use of SIMS to characterize the
effect of an antimicrobial peptide on supported lipid bilayers [232].
The recent development of microﬂuidic devices that permit to ana-
lyze hydrated samples with SIMS [182,233] should provide new oppor-
tunities to study the interaction of exogenous agent with biological
membranes in real-time.
3.2.4. “In silico” approaches
A number of theoretical and computer simulation approaches have
been developed to describe bioactive molecule/lipid interactions,
which vary in the way the system is modelled, and hence in the type
of information that can be obtained from each particular model.
Among others, two “in silico” approaches are interesting. The “docking”
method consists in the systematic analysis of a huge number of posi-
tions of the lipid molecules around the molecule of interest, mimicking
one leaﬂet of the lipid bilayer. Another approach is molecular dynamics
(MD), in which the dynamics of the molecule into the lipid bilayer and
its effects on surrounding lipids is investigated.
3.2.4.1. Docking methods. In the 80s, we have developed a simple theo-
retical method, called Hypermatrix (HM), that allows to surround a bio-
molecule like a drug or a peptide with lipids [234,235]. The molecule of
interest is positioned and ﬁxed for thewhole calculation at the centre of
the system, oriented at the hydrophobic (pho)/hydrophilic (phi) inter-
face. The lipid molecule is also oriented at the pho/phi interface and, by
rotations and translations, more than 107 positions of the lipid around
the central molecule are calculated. The energy values together with
the coordinates of all assemblies are stored in amatrix and classiﬁed ac-
cording to decreasing values (Fig. 3A). Themost stablematching is used
to decide the position of the ﬁrst lipid. The position of the second lipid is
then deﬁned as the nextmost energetically favorable orientation stored
in thematrix taking steric and energetic constraints due to the presence
of the ﬁrst lipid molecule into account. The process ends when the cen-
tral molecule is completely surrounded with lipids. This process simu-
lates the interaction of a biomolecule with a lipid monolayer but the
interfacial behavior of any amphiphile molecule can also be calculated
with this method. In that case, the surrounding molecule is the same
as the central one, forming a monomolecular layer.
In order to account for the presence of two phases, we have devel-
oped an empirical equation for the hydrophobic energy; this equation
is part of the forceﬁeld described in [236]. One limitation of this method
is that the structures of the biomolecule and of the lipids do not change
due to the interaction. However, even with that limitation, and thanks
to the fact that the two phases are considered, parameters such as the
interfacial area of the molecule (lipid or bioactive molecule) are in
very good agreement with the parameters measured experimentally.
For different types of molecules (natural molecules, drugs, lipids,
lipopeptides,…), we have shown a very good agreement (less than 5–
10% difference) for the values of the interfacial area either calculated
Fig. 3. Schematic explanation of HM and BM docking methods. A. In HMmethod, the central molecule stays still while the partner is moving towards and around the central molecule by
rotations and translations (more than 107 positions are tested); both molecules are oriented at pho/phi interface (orange plane). The position and corresponding energy are stored in a
matrix. The molecules are then assembled as described in the text. B. In BM method, the interactions between each pair of molecules are calculated as in HM. The molecules are then
positioned at random in a 600x600molecules grid. The interaction energy is calculated based on the energymatrix and takes into account two layers (red and green squares) ofmolecules
around themolecule of interest (blue patch). Themolecules are permuteduntil the systemenergy reaches aminimumbyusing aMonte Carlominimization procedure. C. Effect of surfactin
concentration on model membrane structure (DOPC/DPPC). Each pixel represents a molecule: DOPC: yellow; DPPC: blue; SF: yellow. The modeling and AFM experiments show that
surfactin inserts at the boundary of DOPC/DPPC domains at low concentration. At higher concentrations, the shape of the lipid domains is signiﬁcantly modiﬁed (adapted from [161]).
a. DOPC/DPPC 1:1 mol/mol. b. DOPC/DPPC/SF 1:1:0.1 mol/mol. c. DOPC/DPPC/SF 1:1:0.3 mol/mol. D. Calculation of the interaction between hederin derivatives and lipids in amonolayer.
Each pixel represents a molecule. The chemical structure of correspondingmolecule is shown above. Αlpha hederinwas shown experimentally to induce phase separation in the presence
of Chol, while for hederagenin, the shape of the domain formed with Chol is very different. Monolayer formation between molar 67% DPMC (red), 23% Chol (green) and 10% of A.
Hederagenin (yellow): B. α hederin (white) (adapted from [116]).
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differing only by the location of the carbonyl group in a ester bond
[237,238] (Table 4). It should be noted that the calculated value corre-
spondsmostly to the experimentalmolecular area inweak compression
conditions.
This docking method is particularly useful to compare the speciﬁc
interaction of the molecule of interest with different lipids and hence
to understand its membrane activity. As an example, the interaction
of hexadecylbetainate chloride (C16BC), belonging to a novel class
of green surfactants, with different mammalian lipids was recentlyTable 4
Comparison between themolecular area calculated by HMmethod and the values determined
the monolayer ﬁlm) by the monolayer Langmuir technique. Cic14 and Coc14 correspond to sy
Molecule Calculated Molecular
area (Å2)
Experimental molecu
area (Å2)
Surfactin 157 154
Cic14 52 49
Coc14 62 65
Glucose octanoate 38 37
Octyl glucuronate 45 44
DMPC 60 65studied: themolecule was shown by calculations and experimentally
to preferentially interact with SM as compared to POPC [239].
In the antibiotics ﬁeld, calculations of the interaction of different
aminoglysoside molecules with lipids have shown a more favorable
interaction energy with PI as compared to other phospholipids. This
preferential interaction has been suggested to be related to their neph-
rotoxicity [217,218].
We have also evidenced a preferential interaction of the nootropic
agent, piracetam, with PE, a non-lamellar lipid necessary for membrane
destabilization and fusion [86]. By speciﬁcally interactingwith this lipid,experimentally (corresponding to A0, i.e. the initial molecular area without compression of
nthetic phenolic molecules.
lar Chemical structure References
See Fig. 4A [238]
Sainvitu, Deleu, Lins, unpublished
id
[237]
[237]
Lins, unpublished
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potential beneﬁcial effect for Alzheimer disease [240].
Other docking methods are also available, such as that used by the
group of Fantini [241,242]: they show a preferential interaction be-
tween Chol and some tilted peptides, identiﬁed by our teamas potential
lipid destabilizing motives [107,243–246].
Very recently, we further improved the HMdocking approach, by in-
creasing the number of interacting partners and the total number of
molecules in the system.We called this new version as “BigMonolayer”
(BM)method. This is a two-steps procedure, in which the ﬁrst step con-
sists in the calculation of paired interactions between the molecules,
derived from the HM method described above. The main difference is
that we calculate the interaction between each molecule under con-
sideration. As an example, in a system composed of DPPC, DOPC and a
lipopeptide (such as surfactin), for each pair of molecules (surfactin/
DPPC, surfactin/DOPC, surfactin/surfactin, DPPC/DPPC, DOPC/DOPC,
DOPC/DPPC), the interaction energies are calculated for a huge number
of positions, as for HM. Another difference is that, in this improved ver-
sion, the statistical Boltzmann energy is considered for each pair ofmol-
ecules, rather than the energy classiﬁcation. The Botzmann energy is
calculated taking into account a Boltzmann statistics corresponding to
the sum of the interaction energy of each relative position testedmulti-
plied by the probability of the position. These interaction energies are
then used in the second step, which consists in the construction of a
grid of n × n molecules (n between 200 and 600) (Fig. 3B), and in the
minimization of the systemusing the values calculated in theﬁrst calcu-
lation step. If n=600, a grid of 360 000molecules, initially positioned at
random, is constructed and the energy of the system is calculated
(Fig. 3B). The energy of onemolecule is equal to the sum of the energies
with its 24 closest neighbors in the grid, i.e. two layers of molecules
around the molecule considered (Fig. 3B). Random permutations are
made and the energy of the new conﬁguration is calculated. By a
Monte Carlo procedure, this new conﬁguration is kept or not, as a func-
tion of the energy difference between the two states. For a grid of
360 000 molecules, one calculation step consists in 360 000 permuta-
tions; 50 000 to 100 000 steps are carried out. For the molecules at the
border of the grid, the molecules at the opposite border are considered
as their closest neighbors, avoiding border limits. Graphically, eachmol-
ecule type is represented by a colored point and all the points are repre-
sented on the grid (Fig. 3C,D).
Thismethod permits to visually observe the preferential interactions
and phase separation between themolecules under consideration. Lipid
phase separation can be simulated, as for DPPC/DOPC equimolar mix-
ture (Fig. 3C). When surfactin is added to that lipid system at different
molar ratios, we observe that the lipopeptide is localized at the edge
of DOPC domains, changing their morphology; this was in very good
agreement with the AFM experiments (Fig. 3C) [161]. In the case of α-
hederin, amember of the saponin family, themolecule is able to interact
speciﬁcally with cholesterol in a DMPC:Chol system, forming domains,
as observed on the BM picture (Fig. 3D) and by ﬂuorescence experi-
ments [116]. This effect is not observed with its related analog,
hederagenin (Fig. 3D).Table 5
Lipid molecules for which MD parameters are accessible, depending on the forceﬁeld.
Forceﬁeld Lipids
CHARMM36 DLPC, DMPC, DPPC, POPC, DOPC, SDPC, DAPC, POPE, Chol
GAFF (AMBER) DLPC, DMPC, DPPC, POPC, DOPC, POPE
Slipids (AMBER) DLPC, DMPC, DPPC, POPC, SOPC, DOPC, DLPE, DPPE, POPE, DOPE,
Berger lipids (Gromos) DMPC, PLPC, DPPC, POPC, DOPC, POPE, SM, Chol
Gromos 43A1-S3 DLPC, DMPC, DPPC, DOPC, POPE, SM, Chol
Gromos 53A6 CKP POPC, DMPG, POPG, DPPE, POPE, CL, lipid A, PIP2
Gromos 53A6 kukol DMPC, DPPC, POPC, POPG
Gromos 53A6 Poger DLPC, DMPC, DPPC, POPC, DOPC
OPLS DPPC, POPC
Martini DHPC, DLPC, DPPC, POPC, DSPC, DOPC, DAPC, DUPC, DHPE, DLPE,3.2.4.2. Molecular dynamics.Molecular dynamics (MD) is a valuable tool
to study interactions between biomolecules and membranes because it
gives access to the atomistic details of the interaction aswell as energet-
ics and dynamics of the observed processes. MD is based on the use of
the motion equations of Newton and on a forceﬁeld to simulate how
an ensemble of atoms moves relative to each other. Forceﬁelds include
potential equations and parameters to reproduce stretching, bending
and rotations of covalent bonds, to maintain planarity and chirality of
several groups aswell as to simulate Van derWaals and electrostatic in-
teractions. The parameters which depend on deﬁning atom types have
been calibrated to reproduce a wide range of experimental values. For
lipid parameters, these values notably include area and volume per
lipid, bilayer thickness and order parameters. Due to the increase in
computational power and the improvement of MD softwares, method-
ologies and forceﬁeld parameters, the use ofMD is becoming an increas-
ingly popular method to study lipid and membrane-related questions.
Typical simulation times are now in the order of 50–100 ns for a hydrat-
ed bilayer of ~100 lipids but simulation times as long as 1 μs have also
been reached [247,248]. The simulation time can also be increased, typ-
ically ranging frommicrosecond to millisecond by using coarse grained
(CG) forceﬁelds, in which groups of atoms are represented by one bead.
Time and length scales are then approaching experimental resolutions
[249]. Several CG forceﬁelds have been developed for lipid molecules
like Klein [250], MARTINI [251] or ELBA models [252]. The popular
MARTINI forceﬁeld allows mixed simulations with proteins [253], car-
bohydrates [254] and has been notably used to study the formation of
lipid domains [255], membrane fusion [256,257], self-assembly of sur-
factant [258,259] or membrane protein oligomerization [260]. Parame-
ters for lipids are now available for the main MD softwares (Table 5), i.e.
Charmm [261–263], Amber [264–267], Gromacs [251,255,268–285],
NAMD [286], and improved parameter sets are frequently added and
compared [264,273,287–291]. These parameters are generally dispersed
over different websites and servers [292,293] but most of them can also
be found on the Lipidbook repository website [293]. Bilayer patches
with different compositions are available on internet [292–295] but
building its own composition is also possible and requires an equili-
bration time around ~100 ns. It can also be done by self-assembly in CG
with or without a reverse transformation or through the use of several
membrane builders which are now available (GCGS [296], MemBuilder
[297], Charmm-GUI [295,298], CELLmicrocosmos [299]). The insertion
of biomoleculeswithin themembrane can be carried out notably through
a self-assembly procedure [300,301] or by using methods such as
g_membed [302] or inﬂategro [303].
Molecular dynamics is used to compute a broad range of values
(position, orientation, structure, dynamics) of the inserted molecule
and its effect on the surrounding lipids that can be correlated with
experimental values. The orientation in the bilayer has notably been
followed for different classes of peptides such as fusion peptides,
WALP peptides, amphiphile or transmembrane peptides; these results
were correlated to ATR-FTIR, NMR or neutron diffraction data [300,
304,305]. MD is also useful to test the stability of peptide conformation
into the membrane [300,306] in correlation with CD, IR or NMRReferences
[262,263,290]
[265]
DLPG, DMPG, DPPG, POPG, DSPG, DOPG, DOPS, SM, Chol [266,267]
[269–272]
[273]
[274–276]
[277]
[278]
[279]
DPPE, POPE, DSPE, DOPE, POPG, DOPG, POPS, DOPS, SM, CL, Chol [251,255,280–285]
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through the lipid order/disorder [307]. Not only peptide/membrane
interaction was studied by MD, but also the interaction between a
broad range of bioactivemolecules, like drugs or glycolipids withmem-
branes has been assessed by this approach [308,309].
Domain formation has also been simulated from different lipid
compositions with CG models, matching the experimentally observed
liquid-ordered and liquid-disordered domains [255,310]. Lipid parti-
tioning and biomolecules sorting between several lipid phases as well
as the effect of biomolecules on phase formation have also been studied
using CG simulations, such as the partition of WALP peptides in the
liquid-disordered phase or the promotion of lipid mixing by vitamin E
[311–313]. The preference of biomolecules for different lipid phases or
compositions can also be assessed by the potential of mean force
(PMF) method that consists in them from the bilayer to bulk water.
Using this method, it was shown that cholesterol has a strongest prefer-
ence for more ordered bilayers [314–316] and inﬂuences the
partitioning of small molecules [317].
Regarding lipid speciﬁcity, the interaction between Chol and dif-
ferent membranotropic peptides has been studied by MD. The lipid-
destabilizing tilted peptides from α synuclein [244], Aβ peptide [318],
and HIV-1 [319], which were also identiﬁed as cholesterol binding
motives, show a perfect ﬁt with Chol through Van der Waals forces
[241,242,320]. A speciﬁc role for Chol has also been suggested in the for-
mation of toroidal pores [321] and in the binding to GM1 ganglioside
[320] of a Aβ peptide fragment.
4. Case study: lipid speciﬁcity of cyclic lipopeptides
Most of the complementary biophysical methods described in this
review have been successfully applied to analyze the interactions of
cyclic lipopeptides (CLPs) with model membranes in terms of lipid
speciﬁcity. CLPs are interesting molecules in the scope of this review
since they combine a peptidic moiety and a lipidic tail and exert their
activity via their interaction with the plasma membrane.
We will focus in this chapter on some CLPs from Bacillus subtilis
strains, namely surfactin, fengycin and mycosubtilin (Fig. 4). Those
molecules were extensively studied in our lab and in the literature in
general.
Surfactin (SF), whose structure is depicted on Fig. 4A, ismainly char-
acterized by its antibacterial and antiviral activities [322]. It has notably
been shown by Langmuir trough that SF is able to penetrate in differentFig. 4. Sequence (above-R represents the alkyl chain) and 3D structure (below) of CLPs
from B. subtiliis: A. Surfactin (3D structure from NMR). B. Mycosubtilin (3D structure is a
model). C. Fengycin (3D structure is a model). For each peptide, a residue is highlighted
as landmark.monolayers constituted by phospholipids (PL) differing in their polar
heads, i.e. DMPC, DMPE or DMPA. The penetration is more important
in DMPC than in DMPE monolayers and is greatly reduced in DMPA
monolayers, probably because of charge repulsion; the addition
of Chol in PL monolayer does not change SF insertion [323]. In mem-
branes, the presence of Chol attenuates the destabilizing effect of
surfactin [324]. This is in accordancewith studies showing a preferential
lysis effect of surfactin on Chol-free liposomes [325] and a higher impact
of SF on red blood cells when Chol content is decreased [326]. The pref-
erence of surfactin for membranes with lower Chol content could ex-
plain why SF preferentially disrupts bacterial membranes lacking Chol.
This sterol effect is speciﬁc to Chol: indeed, stigmasterol has no effect
on surfactin interaction with LUV [127].
According to calculated interactions energies, the association of SF
with DPPC is more favorable than with DPPE or DPPS [327]. PE phos-
pholipids have been shown to attenuate the membrane-perturbing
effect of SF whereas the effect of DPPC was to promote surfactin-
induced leakage [324], indicating that bilayer sensitivity to surfactin in-
creases with the lipid tendency to form lamellar phases. Eeman et al.
[91] have suggested the formation of speciﬁc interactions between SF
and DPPE. Conformational accommodations between the cone-shape
of DPPE and the inverted cone-shape of surfactin as well as the ability
of both DPPE and surfactin polar heads to form, respectively, inter-
and intra-molecular hydrogen bonds lead to believe that speciﬁc inter-
actions such as hydrogen bonding could also exist between PE and SF
molecules.
Moreover, the length of PL acyl chain plays a major role for the pen-
etration, which is increased in the presence of DMPC compared to DPPC
[323]. Grau et al. [328] suggested the formation of complexes between
SF and C14 phospholipids. It has been hypothesized that the interac-
tions between SF and PL alkyl chains are crucial for its insertion into
the membrane [329]. According to another study [91], the lipid mono-
layer thickness and the presence of electrostatic repulsions from the in-
terfacial PL ﬁlm do not signiﬁcantly inﬂuence SF insertion in terms of
kinetics but, in contrast, these parameters strongly modulate the ability
of SF to alter the nanoscale organization of the lipid ﬁlms.
Since surfactin penetration is more important in the presence of PC,
the nanometer scale organization of the mixed SF/DPPC monolayers
have been investigated [330]. A phase separation between DPPC and
SF by the formation of bidimensional domains was observed on AFM
images [161,330]. In these assays, DPPCmolecules have a vertical orien-
tation, with the polar head groups in contact with the mica surface and
the SF peptide ring also laying on the mica [330]. Recent studies have
shown that SF/phospholipid interactions depend not only on the chem-
ical structure of phospholipids but also on their physical properties andFig. 5. Schematic models of the lipid preferential interaction of different CLPs:
(A) Schematic model of the preferential insertion of surfactin into a bilayer composed of
ﬂuid and rigid domains for a SF concentration below the CMC. (B) Illustration of the
preferential interaction ofmycosubtilinwith Chol via the sterol secondary alcohol function
and Tyrosine. (C) Illustration of the suggested preferential interaction of fengycin with
Chol via the sterol secondary alcohol function and the L-tyrosyl residue.
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surfactin exhibits enhanced binding to liposomes containing solid-
ordered domains compared to those with liquid-ordered and liquid-
disordered domains [127]. The presence of rigid domains can play an es-
sential role in the ﬁrst step of surfactin insertion [161]. In this recent
paper, it was suggested that at concentrations below the CMC, SF inserts
at the boundary between gel andﬂuid lipid domains, inhibits phase sep-
aration and stiffens the bilayer without global morphological changes of
liposomes (Fig. 5A). At concentrations close to CMC, surfactin solubilizes
the ﬂuid PL phase and increases order in the remainder of the lipid
bilayer. At higher SF concentrations, both the ﬂuid and the rigid bilayer
structures are dissolved into mixed micelles and other structures pre-
senting a wide size distribution.
Mycosubtilin (Fig. 4B), another lipopeptide from Bacillus sp. has also
been widely investigated; it is the most active member of iturin
lipopeptide family known as powerful antifungal agents [204,331].
The initial studies have shown that mycosubtilin binds efﬁciently to
bilayers constituted by DPPC and DPPC and Chol [208]. This was con-
ﬁrmed by the increase of ion permeability of planar membranes in-
duced by mycosubtilin, especially in the presence of Chol [332]. In the
same way, mycosubtilin and Chol interact strongly in monolayers in
all proportions and form a mycosubtilin–Chol (1:2) complex [332]. In
the light of these ﬁrst results, it has been suggested that the action of
mycosubtilin takes place by the formation of ternary mixture constitut-
ed bymycosubtilin, phospholipids and sterols [331]. A systematic study
of the interactions of mycosubtilin with different lipid monolayers
showed that the penetration of the lipopeptidewithin lipid monolayers
was more important in the presence of sterols such as Chol and ergos-
terol [79,86,92,204]. The importance of the secondary alcohol function
of sterols for mycosubtilin penetration was highlighted since its sup-
pression via acetylation drastically decreases the penetration of the
lipopeptide [79,92]. Yet, the synergic effect of sphingomyelin, DPPC
and Chol on the mycosubtilin penetration was the most interesting re-
sults, suggesting a privileged interaction of the lipopeptide with
sterol-enriched microdomains of sensitive cells [79,92]. At the molecu-
lar level, mycosubtilin interacts with the PL alkyl chains, inducing a ﬂu-
idizing effect in which the β-amino fatty acyl residue is involved [86,
204]. Moreover, a modiﬁcation of the peptide backbone conformation
and the involvement of the Tyr residue have been observed by IR spec-
troscopy (as mentioned above) when the peptide interacts with sterol-
containing liposomes [79]. Taking together, these ﬁndings suggest a
preferential interaction between the sterol secondary alcohol function
and the tyrosyl residue, which seems to be crucial for the biological ac-
tivity of the lipopeptide [79] (Fig. 5B). This is further assessed by nonlin-
ear optics measurements developed to follow speciﬁcally the Tyr
residue at the air–water interface [92,203,206]. Indeed, in the presence
of sterol monolayers, the orientation of tyrosine changed drastically,
contrarily to other residues [207].
Like mycosubtilin, fengycin is an antifungal lipopeptide synthetized
by B. subtilis strains and is constituted by ten amino acids (eight of
them forming a cyclic structure) and by a β-hydroxy fatty acid chain
linked to the peptide cycle (Fig. 4C) [333]. Fengycin has two acidic and
one basic residues and it is therefore negatively charged [334].
In mixed monolayers, fengycin interacts with DPPC with a ﬂuidizing
effect, inducing a signiﬁcant perturbation of the lipid organization
[335]. Partial dissolution of DPPC condensed domains was shown by
AFM, underlying the role played by the physical state of the lipid on
fengycin-membrane interactions [187]. Moreover, a recent study
showed that fengycin is poorly miscible with ﬂuid lipids [336]. MD sim-
ulations show that fengycin promotes positive curvature in POPE/POPG,
DPPC and POPC bilayer systems. It has a preferential interaction with
anionic POPG lipids (as compared to POPC and DPPC), with an attractive
behavior despite the expected charge repulsion [173]. Fengycin has the
capacity to modulate the formation of 2D domains in skin membrane
[146]. This CLP is able to interact with the lipid constituents of the extra-
cellular matrix of stratum corneum [152]. In particular, it has beenshown that the presence of Chol facilitates fengycin incorporation, as
assessed by the partition of fengycin into Chol-rich phases [152].
As for mycosubtilin, the involvement of Tyr residue and the secondary
alcohol group of Chol during fengycin/Chol interactions must be
conﬁrmed by testing the interactions of this lipopeptide with
cholesterylacetatemonolayers and by looking for the antifungal activity
of the Tyr-methylated or -acetylated fengycin. The potential interaction
between Tyr and Chol is illustrated on Fig. 5C.
5. Conclusions and perspectives
The exact manner by which bioactive molecules interact with PM
and molecular details of this mechanism is an area of active research,
as shown by the numerous examples cited in this review, and also a
matter of intensive debate in some cases. The use of model membranes
with speciﬁc lipid composition is a way to circumvent the high com-
plexity of the natural lipid bilayer and to focus on lipid speciﬁcity.
Biophysical tools are amajorway to understand these processes and
can help solving problems of biological importance. In this review, we
have listed some of these techniques, others are available, but it is im-
portant to stress the complementarity between all these approaches,
giving a detailed picture of what is happening at the molecular level.
The constant evolution of the biophysical techniques, such as mass
spectrometry, will provide in near future a better correlation between
in vitro and in vivo studies. Techniques that allow monitoring living
cell membranes at molecular (even atomic) resolution are constantly
being improved and should help to better understand this complex li-
pidic structure and the processes occurring at its interface.
As a conclusion, a better understanding of the interaction between
biomolecules and the plasma membrane at the molecular level, and
more speciﬁcally with one particular lipid, is not only important in the
elucidation of various biological processes but could also serve to design
molecules with tailored functionalities for drug development, especially
in the ﬁeld of health, such as antibiotic and drug delivery developments.
Furthermore, the cell membrane is often overlooked in this area since it
is not the target of the pharmacological molecule as such. However, the
interaction of most of these exogeneous amphiphilic compounds with
the plasma membrane can inﬂuence its structure and hence its normal
function.
On the other hand, ﬁelds such as biocontrol for plants could also
beneﬁt from advances in the biophysical elucidation of the interaction
between natural bioactive molecules and plant lipids. Indeed, under-
standing how molecules from the rhizosphere help plant to be
protected by acting speciﬁcally on membranes and eliciting plant de-
fense mechanisms should lead to the design of potent biobased mole-
cules, avoiding an overuse of chemical pesticides.
Acknowledgments
We want to thank the groups of Prof MP Mingeot-Leclercq (LDRI,
UCL, Belgium) and of Prof T. Nylander (Physical Chemistry 1, Lund
University, Sweden) for our long lasting fruitful collaboration.
We thank Prof Robert Brasseur, who is now retired, for the concep-
tion of the algorithm Hypermatrix and its recently improved version
“Big Monolayer”.
We thank the FNRS, the Belgian Program on Interuniversity Attrac-
tion Poles initiated by the Federal Ofﬁce for Scientiﬁc, Technical and Cul-
tural Affairs (IAP P7/44 iPros), The University of Liège (Fonds Spéciaux
de la Recherche, Action de Recherche Concertée-Projet FIELD) for ﬁnan-
cial support.
MD and LL are Senior Research Associates for the Fonds National de
la Recherche Scientiﬁque (FRS-FNRS), JMC is supported by the IAP iPros
project and MNN by the ARC FIELD project.
Partial computational resources of the lab are provided by the
“Consortium des Équipements de Calcul Intensif” (CÉCI), funded by
the F.R.S.-FNRS under Grant No. 2.5020.11.
3184 M. Deleu et al. / Biochimica et Biophysica Acta 1838 (2014) 3171–3190References
[1] F. Furt, F. Simon-Plas, S. Mongrand, The Plant Plasma Membrane, Springer Berlin
Heidelberg, Berlin, Heidelberg, 2011., http://dx.doi.org/10.1007/978-3-642-
13431-9.
[2] G. van Meer, D.R. Voelker, G.W. Feigenson, Membrane lipids: where they are and
how they behave, Nat. Rev. Mol. Cell Biol. 9 (2008) 112–124, http://dx.doi.org/
10.1038/nrm2330.
[3] A.M. Seddon, D. Casey, R.V. Law, A. Gee, R.H. Templer, O. Ces, Drug interactions
with lipid membranes, Chem. Soc. Rev. 38 (2009) 2509–2519.
[4] M.A. Sani, F. Separovic, J.D. Gehman, The lipid network, Biophys. Rev. 4 (2012)
283–290.
[5] K. Lohner, E.J. Prenner, Differential scanning calorimetry and X-ray diffraction stud-
ies of the speciﬁcity of the interaction of antimicrobial peptides with membrane-
mimetic systems, Biochim. Biophys. Acta (BBA) 1462 (1999) 141–156.
[6] J.S. Owen, K.R. Bruckdorfer, R.C. Day, N. McIntyre, Decreased erythrocyte mem-
brane ﬂuidity and altered lipid composition in human liver disease, J. Lipid Res.
23 (1982) 124–132.
[7] S. Sahu, W.S. Lynn, Lipid composition of human alveolar macrophages, Inﬂamma-
tion 2 (1977) 83–91, http://dx.doi.org/10.1007/BF00918670.
[8] D.R. Voelker, Lipid assembly into cell membranes, in: J.E. Vance, D. Vance (Eds.),
4th ed., Biochem. Lipids, Lipoproteins Membr., 2002, pp. 449–482.
[9] T. Heimburg, Thermal Biophysics of Membranes, Wiley-VCH Verlag GmbH & Co.
KGaA, Weinheim, Germany, 2007., http://dx.doi.org/10.1002/9783527611591.
[10] K. Schrick, U.Mayer, G.Martin, C. Bellini, C. Kuhnt, J. Schmidt, et al., Interactions be-
tween sterol biosynthesis genes in embryonic development of Arabidopsis, Plant J.
31 (2002) 61–73, http://dx.doi.org/10.1046/j.1365-313X.2002.01333.x.
[11] P. Benveniste, Biosynthesis and accumulation of sterols, Annu. Rev. Plant Biol. 55
(2004) 429–457, http://dx.doi.org/10.1146/annurev.arplant.55.031903.141616.
[12] J.-L. Cacas, F. Furt, M. Le Guédard, J.-M. Schmitter, C. Buré, P. Gerbeau-Pissot, et al.,
Lipids of plant membrane rafts, Prog. Lipid Res. 51 (2012) 272–299, http://dx.doi.
org/10.1016/j.plipres.2012.04.001.
[13] C. Buré, J.-L. Cacas, S. Mongrand, J.-M. Schmitter, Characterization of glycosyl inosi-
tol phosphoryl ceramides from plants and fungi by mass spectrometry, Anal.
Bioanal. Chem. 406 (2014) 995–1010, http://dx.doi.org/10.1007/s00216-013-
7130-8.
[14] C. Buré, J.-L. Cacas, F. Wang, K. Gaudin, F. Domergue, S. Mongrand, et al., Fast
screening of highly glycosylated plant sphingolipids by tandem mass spectrome-
try, Rapid Commun. Mass Spectrom. 25 (2011) 3131–3145, http://dx.doi.org/10.
1002/rcm.5206.
[15] R.C. Dickson, E.E. Nagiec, G.B.Wells, M.M. Nagiec, R.L. Lester, Synthesis ofmannose-
(inositol-P)2-ceramide, the major sphingolipid in Saccharomyces cerevisiae, re-
quires the IPT1 (YDR072c) gene, J. Biol. Chem. 272 (1997) 29620–29625, http://
dx.doi.org/10.1074/jbc.272.47.29620.
[16] F.J. Alvarez, L.M. Douglas, J.B. Konopka, Sterol-rich plasma membrane domains in
fungi, Eukaryot. Cell 6 (2007) 755–763, http://dx.doi.org/10.1128/EC.00008-07.
[17] G. Daum, G. Tuller, T. Nemec, C. Hrastnik, G. Balliano, L. Cattel, et al., Systematic
analysis of yeast strains with possible defects in lipid metabolism, Yeast 15
(1999) 601–614, http://dx.doi.org/10.1002/(SICI)1097-0061(199905)15:7b601::
AID-YEA390N3.0.CO;2-N.
[18] G.M. Carman, G.M. Zeimetz, Regulation of phospholipid biosynthesis in the YEast
Saccharomyces cerevisiae, J. Biol. Chem. 271 (1996) 13293–13296, http://dx.doi.
org/10.1074/jbc.271.23.13293.
[19] R.M. Epand, R.F. Epand, Bacterial membrane lipids in the action of antimicrobial
agents, J. Pept. Sci. 17 (2011) 298–305, http://dx.doi.org/10.1002/psc.1319.
[20] R.F. Epand, P.B. Savage, R.M. Epand, Bacterial lipid composition and the antimicro-
bial efﬁcacy of cationic steroid compounds (Ceragenins), Biochim. Biophys. Acta
1768 (2007) 2500–2509, http://dx.doi.org/10.1016/j.bbamem.2007.05.023.
[21] K. Simons, E. Ikonen, Functional rafts in cell membranes, Nature 387 (1997)
569–572, http://dx.doi.org/10.1038/42408.
[22] K. Simons, J.L. Sampaio, Membrane organization and lipid rafts, Cold Spring Harb.
Perspect. Biol. 3 (2011) a004697, http://dx.doi.org/10.1101/cshperspect.a004697.
[23] P.F.F. Almeida, A. Pokorny, A. Hinderliter, Thermodynamics of membrane domains,
Biochim. Biophys. Acta 1720 (2005) 1–13, http://dx.doi.org/10.1016/j.bbamem.
2005.12.004.
[24] T.G. Pomorski, T. Nylander, M. Cárdenas, Model cell membranes: discerning lipid
and protein contributions in shaping the cell, Adv. Colloid Interf. Sci. 205C
(2014) 207–220, http://dx.doi.org/10.1016/j.cis.2013.10.028.
[25] B.P. Head, H.H. Patel, P.A. Insel, Interaction of membrane/lipid rafts with the cyto-
skeleton: impact on signaling and function: membrane/lipid rafts, mediators of cy-
toskeletal arrangement and cell signaling, Biochim. Biophys. Acta 1838 (2014)
532–545.
[26] L. D'Auria, M. Fenaux, P. Aleksandrowicz, P. Van Der Smissen, C. Chantrain, C.
Vermylen, et al., Micrometric segregation of ﬂuorescent membrane lipids: rele-
vance for endogenous lipids and biogenesis in erythrocytes, J. Lipid Res. 54
(2013) 1066–1076, http://dx.doi.org/10.1194/jlr.M034314.
[27] L. D'auria, P. Van der Smissen, F. Bruyneel, P.J. Courtoy, D. Tyteca, Segregation of
ﬂuorescent membrane lipids into distinct micrometric domains: evidence for
phase compartmentation of natural lipids? PLoS One 6 (2011) e17021, http://dx.
doi.org/10.1371/journal.pone.0017021.
[28] C. Peetla, A. Stine, V. Labhasetwar, Biophysical interactions with model lipid mem-
branes: applications in drug discovery and drug delivery, Mol. Pharm. 6 (2009)
1264–1276.
[29] M. Eeman, M. Deleu, From biological membranes to biomimetic model mem-
branes, Biotechnol. Agron. Soc. Environ. 14 (2010) 719–736.[30] R. Maget-Dana, Themonolayer technique: a potent tool for studying the interfacial
properties of antimicrobial and membrane-lytic peptides and their interactions
with lipid membranes, Biochim. Biophys. Acta Biomembr. 1462 (1999) 109–140,
http://dx.doi.org/10.1016/S0005-2736(99)00203-5.
[31] G. Brezesinski, H. Möhwald, Langmuir monolayers to study interactions at model
membrane surfaces, Adv. Colloid Interf. Sci. 100–102 (2003) 563–584, http://dx.
doi.org/10.1016/S0001-8686(02)00071-4.
[32] M. Eeman, M. Deleu, Des membranes biologiques aux modèles membranaires
biomimétiques, Biotechnol. Agron. Soc. Environ. 14 (2010) 719–736.
[33] C. Rossi, J. Chopineau, Biomimetic tethered lipid membranes designed for mem-
brane–protein interaction studies, Eur. Biophys. J. 36 (2007) 955–965, http://dx.
doi.org/10.1007/s00249-007-0202-y.
[34] F. Tiberg, I. Harwigsson, M. Malmsten, Formation of model lipid bilayers at the sil-
ica–water interface by co-adsorption with non-ionic dodecyl maltoside surfactant,
Eur. Biophys. J. 29 (2000) 196–203.
[35] H.P. Vacklin, F. Tiberg, R.K. Thomas, Formation of supported phospholipid bilayers
via co-adsorption with beta-D-dodecyl maltoside, Biochim. Biophys. Acta 1668
(2005) 17–24, http://dx.doi.org/10.1016/j.bbamem.2004.11.001.
[36] C. Lee, H.Wacklin, C.D. Bain, Changes inmolecular composition and packing during
lipid membrane reconstitution from phospholipid–surfactant micelles, Soft Matter
5 (2009) 568, http://dx.doi.org/10.1039/b812768a.
[37] J.Y. Wong, J. Majewski, M. Seitz, C.K. Park, J.N. Israelachvili, G.S. Smith, Polymer-
cushioned bilayers. I. A structural study of various preparation methods using neu-
tron reﬂectometry, Biophys. J. 77 (1999) 1445–1457.
[38] D. Alex, Methods in Membrane Lipids, Humana Press, New Jersey, 2007., http://dx.
doi.org/10.1385/1597455199.
[39] M.-P. Mingeot-Leclercq, M. Deleu, R. Brasseur, Y.F. Dufrêne, Atomic force microsco-
py of supported lipid bilayers, Nat. Protoc. 3 (2008) 1654–1659, http://dx.doi.org/
10.1038/nprot.2008.149.
[40] E.I. Goksu, J.M. Vanegas, C.D. Blanchette, W.-C. Lin, M.L. Longo, AFM for structure
and dynamics of biomembranes, Biochim. Biophys. Acta 1788 (2009) 254–266,
http://dx.doi.org/10.1016/j.bbamem.2008.08.021.
[41] Y.-H.M. Chan, S.G. Boxer, Model membrane systems and their applications, Curr.
Opin. Chem. Biol. 11 (2007) 581–587, http://dx.doi.org/10.1016/j.cbpa.2007.09.
020.
[42] G. Puu, I. Gustafson, Planar lipid bilayers on solid supports from liposomes—factors
of importance for kinetics and stability, Biochim. Biophys. Acta Biomembr. 1327
(1997) 149–161, http://dx.doi.org/10.1016/S0005-2736(97)00052-7.
[43] C. Keller, B. Kasemo, Surface speciﬁc kinetics of lipid vesicle adsorption measured
with a quartz crystal microbalance, Biophys. J. 75 (1998) 1397–1402, http://dx.
doi.org/10.1016/S0006-3495(98)74057-3.
[44] C.E. Miller, J. Majewski, T.L. Kuhl, Characterization of single biological membranes
at the solid–liquid interface by X-ray reﬂectivity, Colloids Surf. A Physicochem.
Eng. Asp. 284–285 (2006) 434–439, http://dx.doi.org/10.1016/j.colsurfa.2005.11.
059.
[45] H.P. Wacklin, R.K. Thomas, Spontaneous formation of asymmetric lipid bilayers by
adsorption of vesicles, Langmuir 23 (2007) 7644–7651, http://dx.doi.org/10.1021/
la063476q.
[46] D.D. Lasic, On the thermodynamic stability of liposomes, J. Colloid Interface Sci. 140
(1990) 302–304.
[47] H. Madani, E.W. Kaler, Aging and stability of vesicular dispersions, Langmuir 6
(1990) 125–132.
[48] E.F. Marques, Size and Stability of Catanionic Vesicles: Effects of Formation Path,
Sonication, and Aging, 2000. 4798–4807.
[49] G. Gregoriadis, Overview of liposomes, J. Antimicrob. Chemother. (1991) 39–48.
[50] B. Mui, L. Chow, M.J. Hope, Extrusion technique to generate liposomes of deﬁned
size, Methods Enzymol. 367 (2003) 3–14, http://dx.doi.org/10.1016/S0076-
6879(03)67001-1.
[51] M. Uhumwangho, R. Okor, Current trends in the production and biomedical appli-
cations of liposomes: a review, J. Med. Biomed. Res. 4 (2009), http://dx.doi.org/10.
4314/jmbr.v4i1.10663.
[52] A. Lorin, C. Flore, A. Thomas, R. Brasseur, Les liposomes: description, fabrication et
applications, Biotechnol. Agron. Soc. Environ. 8 (2004) 163–176.
[53] H. Bensikaddour, K. Snoussi, L. Lins, F. Van Bambeke, P.M. Tulkens, R. Brasseur, et al.,
Interactions of ciproﬂoxacin with DPPC and DPPG: ﬂuorescence anisotropy, ATR-
FTIR and 31 P NMR spectroscopies and conformational analysis, BBA Biomembr.
1778 (2008) 2535–2543, http://dx.doi.org/10.1016/j.bbamem.2008.08.015.
[54] H. Bensikaddour, N. Fa, I. Burton, M. Deleu, L. Lins, A. Schanck, et al., Characteriza-
tion of the interactions between ﬂuoroquinolone antibiotics and lipids: a
multitechnique approach, Biophys. J. 94 (2008) 3035–3046, http://dx.doi.org/10.
1529/biophysj.107.114843.
[55] N. Fa, L. Lins, P.J. Courtoy, Y. Dufrêne, P. Van Der Smissen, R. Brasseur, et al., De-
crease of elastic moduli of DOPC bilayers induced by a macrolide antibiotic,
azithromycin, Biochim. Biophys. Acta 1768 (2007) 1830–1838, http://dx.doi.org/
10.1016/j.bbamem.2007.04.013.
[56] N. Fa, S. Ronkart, A. Schanck, M. Deleu, A. Gaigneaux, E. Goormaghtigh, et al., Effect
of the antibiotic azithromycin on thermotropic behavior of DOPC or DPPC bilayers,
Chem. Phys. Lipids 144 (2006) 108–116, http://dx.doi.org/10.1016/j.chemphyslip.
2006.08.002.
[57] A. Berquand, M.-P. Mingeot-Leclercq, Y.F. Dufrêne, Real-time imaging of drug–
membrane interactions by atomic force microscopy, Biochim. Biophys. Acta 1664
(2004) 198–205, http://dx.doi.org/10.1016/j.bbamem.2004.05.010.
[58] C. Rodrigues, P. Gameiro, S. Reis, J.L.F. Lima, B. de Castro, Derivative spectropho-
tometry as a tool for the determination of drug partition coefﬁcients in water/
dimyristoyl-l-α-phosphatidylglycerol (DMPG) liposomes, Biophys. Chem. 94
(2001) 97–106, http://dx.doi.org/10.1016/S0301-4622(01)00227-7.
3185M. Deleu et al. / Biochimica et Biophysica Acta 1838 (2014) 3171–3190[59] M. Baciu, S.C. Sebai, O. Ces, X. Mulet, J.A. Clarke, G.C. Shearman, et al., Degradative
transport of cationic amphiphilic drugs across phospholipid bilayers, Philos. Trans.
A. Math. Phys. Eng. Sci. 364 (2006) 2597–2614, http://dx.doi.org/10.1098/rsta.
2006.1842.
[60] W.I. Gruszecki, M. Gagoś, M. Hereć, P. Kernen, Organization of antibiotic
amphotericin B in model lipid membranes. A mini review, Cell. Mol. Biol. Lett. 8
(2003) 161–170.
[61] M. Baginski, J. Czub, K. Sternal, Interaction of amphotericin B and its selected deriv-
atives with membranes: molecular modeling studies, Chem. Rec. 6 (2006)
320–332, http://dx.doi.org/10.1002/tcr.20096.
[62] I.M. Torcato, M.A.R.B. Castanho, S.T. Henriques, The application of biophysical tech-
niques to study antimicrobial peptides, Spectrosc. An Int. J. 27 (2012) 541–549,
http://dx.doi.org/10.1155/2012/460702.
[63] S. Galdiero, A. Falanga, M. Cantisani, M. Vitiello, G. Morelli, M. Galdiero, Peptide–
lipid interactions: experiments and applications, Int. J. Mol. Sci. 14 (2013)
18758–18789, http://dx.doi.org/10.3390/ijms140918758.
[64] K. Lohner, New strategies for novel antibiotics: peptides targeting bacterial cell
membranes, Gen. Physiol. Biophys. 28 (2009) 105–116, http://dx.doi.org/10.
4149/gpb_2009_02_105.
[65] M.U. Hammer, A. Brauser, C. Olak, G. Brezesinski, T. Goldmann, T. Gutsmann, et al.,
Lipopolysaccharide interaction is decisive for the activity of the antimicrobial pep-
tide NK-2 against Escherichia coli and Proteus mirabilis, Biochem. J. 427 (2010)
477–488, http://dx.doi.org/10.1042/BJ20091607.
[66] J.R. Brender, A.J. McHenry, A. Ramamoorthy, Does cholesterol play a role in the bac-
terial selectivity of antimicrobial peptides? Front. Immunol. 3 (2012) 195, http://
dx.doi.org/10.3389/ﬁmmu.2012.00195.
[67] G. Caracciolo, H. Amenitsch, Cationic liposome/DNA complexes: from structure to
interactions with cellular membranes, Eur. Biophys. J. 41 (2012) 815–829, http://
dx.doi.org/10.1007/s00249-012-0830-8.
[68] C. Madeira, L.M.S. Loura, M.R. Aires-Barros, M. Prieto, Fluorescence methods for
lipoplex characterization, Biochim. Biophys. Acta 1808 (2011) 2694–2705, http://
dx.doi.org/10.1016/j.bbamem.2011.07.020.
[69] H. Gao, Probing mechanical principles of cell–nanomaterial interactions, J. Mech.
Phys. Solids 62 (2014) 312–339, http://dx.doi.org/10.1016/j.jmps.2013.08.018.
[70] M. Schulz, A. Olubummo, W.H. Binder, Beyond the lipid-bilayer: interaction of
polymers and nanoparticles with membranes, Soft Matter 8 (2012) 4849, http://
dx.doi.org/10.1039/c2sm06999g.
[71] Y. Kim, Y. Kwak, R. Chang, Free energy of PAMAM dendrimer adsorption onto
model biological membranes, J. Phys. Chem. B 118 (2014) 6792–6802, http://dx.
doi.org/10.1021/jp501755k.
[72] B. J.R., B.G. Orr, M.M.B. Holl, Nanoparticle interactions with biological membranes:
dendrimers as experimental exemplars and a proposed physical mechanism,
Nanotoxicology (2007) 456.
[73] H. Lee, R.G. Larson, Multiscale modeling of dendrimers and their interactions with
bilayers and polyelectrolytes, Molecules 14 (2009) 423–438, http://dx.doi.org/10.
3390/molecules14010423.
[74] A. Åkesson, C.V. Lundgaard, N. Ehrlich, T.G. Pomorski, D. Stamou, M.
Cárdenas, Induced dye leakage by PAMAM G6 does not imply dendrimer
entry into vesicle lumen, Soft Matter 8 (2012) 8972, http://dx.doi.org/10.
1039/c2sm25864a.
[75] E. Amado, J. Kressler, Interactions of amphiphilic block copolymers with lipid
model membranes, Curr. Opin. Colloid Interface Sci. 16 (2011) 491–498, http://
dx.doi.org/10.1016/j.cocis.2011.07.003.
[76] J.K.L. Mary, T. Le, E.J. Prenner, Biomimetic model membrane systems serve as in-
creasingly valuable in vitro tools, in: Marko Cavrak (Ed.), Adv. Biomimetics, InTech,
2011, pp. 252–269, http://dx.doi.org/10.5772/574.
[77] J. Miñones, S. Pais, O. Conde, P. Dynarowicz-Łatka, Interactions betweenmembrane
sterols and phospholipids in model mammalian and fungi cellular membranes—a
Langmuir monolayer study, Biophys. Chem. 140 (2009) 69–77, http://dx.doi.org/
10.1016/j.bpc.2008.11.011.
[78] K. Boesze-Battaglia, R. Schimmel, Cell membrane lipid composition and distribu-
tion: implications for cell function and lessons learned from photoreceptors and
platelets, J. Exp. Biol. 200 (1997) 2927–2936.
[79] M.N. Nasir, F.F. Besson, Speciﬁc interactions of mycosubtilin with cholesterol-
containing artiﬁcial membranes, Langmuir 27 (2011) 10785–10792, http://dx.
doi.org/10.1021/la200767e.
[80] A.S. Murphy, W. Peer, B. Schulz, The Plant Plasma Membrane (Google eBook),
Springer, 2010.
[81] C. Silva, F.J. Aranda, A. Ortiz, V. Martínez, M. Carvajal, J.A. Teruel, Molecular aspects
of the interaction between plants sterols and DPPC bilayers: an experimental and
theoretical approach, J. Colloid Interface Sci. 358 (2011) 192–201, http://dx.doi.
org/10.1016/j.jcis.2011.02.048.
[82] F. Jean-François, B. Desbat, E.J. Dufourc, Selectivity of cateslytin for fungi: the role of
acidic lipid-ergosterol membrane ﬂuidity in antimicrobial action, FASEB J. 23
(2009) 3692–3701, http://dx.doi.org/10.1096/fj.09-135574.
[83] M.N. Nasir, F. Besson, Conformational analyses of bacillomycin D, a natural antimi-
crobial lipopeptide, alone or in interaction with lipid monolayers at the air–water
interface, J. Colloid Interface Sci. 387 (2012) 187–193, http://dx.doi.org/10.1016/j.
jcis.2012.07.091.
[84] P. Calvez, E. Demers, E. Boisselier, C. Salesse, Analysis of the contribution of saturat-
ed and polyunsaturated phospholipid monolayers to the binding of proteins, Lang-
muir 27 (2011) 1373–1379, http://dx.doi.org/10.1021/la104097n.
[85] S. Gatard, M.N. Nasir, M. Deleu, N. Klai, V. Legrand, S. Bouquillon, Bolaamphiphiles
derived from alkenyl L-rhamnosides and alkenyl D-xylosides: importance of the
hydrophilic head, Molecules 18 (2013) 6101–6112, http://dx.doi.org/10.3390/
molecules18056101.[86] M.N. Nasir, A. Thawani, A. Kouzayha, F. Besson, Interactions of the natural antimi-
crobial mycosubtilin with phospholipid membrane models, Colloids Surf. B:
Biointerfaces 78 (2010) 17–23, http://dx.doi.org/10.1016/j.colsurfb.2010.01.034.
[87] G.L. Gaines, Insoluble Monolayers at Liquid–gas Interfaces, Interscience Publishers,
New York, 1966.
[88] P. Dynarowicz-Łątka, A. Dhanabalan, O.N. Oliveira, Modern physicochemical re-
search on Langmuir monolayers, Adv. Colloid Interf. Sci. 91 (2001) 221–293,
http://dx.doi.org/10.1016/S0001-8686(99)00034-2.
[89] J.J. Giner-Casares, G. Brezesinski, H. Möhwald, Langmuir monolayers as unique
physical models, Curr. Opin. Colloid Interface Sci. (2013), http://dx.doi.org/10.
1016/j.cocis.2013.07.006.
[90] C. Stefaniu, G. Brezesinski, H. Möhwald, Langmuir monolayers as models to study
processes at membrane surfaces, Adv. Colloid Interf. Sci. (2014), http://dx.doi.
org/10.1016/j.cis.2014.02.013.
[91] M. Eeman, A. Berquand, Y.F. Dufrêne, M. Paquot, S. Dufour, M. Deleu, Penetration of
surfactin into phospholipid monolayers: nanoscale interfacial organization, Lang-
muir 22 (2006) 11337–11345, http://dx.doi.org/10.1021/la061969p.
[92] M.N. Nasir, F. Besson, Interactions of the antifungal mycosubtilin with ergosterol-
containing interfacial monolayers, Biochim. Biophys. Acta Biomembr. 1818
(2012) 1302–1308, http://dx.doi.org/10.1016/j.bbamem.2012.01.020.
[93] K. Ariga, Y. Yamauchi, T. Mori, J.P. Hill, 25th anniversary article: what can be done
with the Langmuir–Blodgett method? Recent developments and its critical role in
materials science, Adv. Mater. 25 (2013) 6477–6512, http://dx.doi.org/10.1002/
adma.201302283.
[94] E.T. Castellana, P.S. Cremer, Solid supported lipid bilayers: from biophysical studies
to sensor design, Surf. Sci. Rep. 61 (2006) 429–444, http://dx.doi.org/10.1016/j.
surfrep.2006.06.001.
[95] L.K. Tamm, H.M. McConnell, Supported phospholipid bilayers, Biophys. J. 47 (1985)
105–113, http://dx.doi.org/10.1016/S0006-3495(85)83882-0.
[96] N. Düzgüneş, H. Faneca, M.C. Lima, Methods to monitor liposome fusion, perme-
ability, and interaction with cells, Methods Mol. Biol. 606 (2010) 209–232,
http://dx.doi.org/10.1007/978-1-60761-447-0_16.
[97] A.S. Ladokhin, S. Jayasinghe, S.H. White, How to measure and analyze tryptophan
ﬂuorescence in membranes properly, and why bother? Anal. Biochem. 285
(2000) 235–245, http://dx.doi.org/10.1006/abio.2000.4773.
[98] B. Christiaens, S. Symoens, S. Vanderheyden, Y. Engelborghs, A. Joliot, A. Prochiantz,
et al., Tryptophan ﬂuorescence study of the interaction of penetratin peptides with
model membranes, Eur. J. Biochem. 269 (2002) 2918–2926, http://dx.doi.org/10.
1046/j.1432-1033.2002.02963.x.
[99] J.N. Weinstein, S. Yoshikami, P. Henkart, Liposome cell interaction: Transfer and in-
tracellular release of a trapped ﬂuorescent marker, 1977.
[100] A.M. Garcia, Determination of ion permeability by ﬂuorescence quenching,
Methods Enzymol. 207 (1992) 501–510.
[101] H. Ellens, J. Bentz, F.C. Szoka, H+- and Ca2+-induced fusion and destabilization of
liposomes, Biochemistry 24 (1985) 3099–3106.
[102] J. Wilschut, D. Papahadjopoulos, Ca2+-induced fusion of phospholipid vesicles
monitored by mixing of aqueous contents, Nature 281 (1979) 690–692.
[103] D. Hoekstra, N. Duzgunes, Lipidmixing assays to determine fusion in liposome sys-
tems, Methods Enzymol. 220 (1993) 15–32.
[104] D.K. Struck, D. Hoekstra, R.E. Pagano, Use of resonance energy transfer to monitor
membrane fusion, Biochemistry 20 (1981) 4093–4099.
[105] L.M.S. Loura, F. Fernandes, M. Prieto, Membrane microheterogeneity: Förster reso-
nance energy transfer characterization of lateral membrane domains, Eur. Biophys.
J. 39 (2010) 589–607, http://dx.doi.org/10.1007/s00249-009-0547-5.
[106] L. Lins, C. Flore, L. Chapelle, P.J. Talmud, A. Thomas, R. Brasseur, Lipid-interacting
properties of the N-terminal domain of human apolipoprotein C-III, Protein Eng.
15 (2002) 513–520.
[107] L. Lins, R. Brasseur, Tilted peptides: a structural motif involved in protein mem-
brane insertion? J. Pept. Sci. 14 (2008) 416–422, http://dx.doi.org/10.1002/psc.
971.
[108] T. Parasassi, E.K. Krasnowska, L. Bagatolli, E. Gratton, Laurdan and Prodan as
polarity-sensitive ﬂuorescent membrane probes, J. Fluoresc. 8 (1998) 365–373.
[109] L.A. Bagatolli, To see or not to see: lateral organization of biological membranes
and ﬂuorescence microscopy, Biochim. Biophys. Acta 1758 (2006) 1541–1556,
http://dx.doi.org/10.1016/j.bbamem.2006.05.019.
[110] L.A. Bagatolli, Microscopy imaging of membrane domains, Biochim. Biophys. Acta
1798 (2010) 1285, http://dx.doi.org/10.1016/j.bbamem.2010.05.023.
[111] L. Jin, A.C. Millard, J.P. Wuskell, X. Dong, D. Wu, H.A. Clark, et al., Characterization
and application of a new optical probe for membrane lipid domains, Biophys. J.
90 (2006) 2563–2575, http://dx.doi.org/10.1529/biophysj.105.072884.
[112] J.M. Kwiatek, D.M. Owen, A. Abu-Siniyeh, P. Yan, L.M. Loew, K. Gaus, Characteriza-
tion of a new series of ﬂuorescent probes for imaging membrane order, PLoS One 8
(2013) e52960, http://dx.doi.org/10.1371/journal.pone.0052960.
[113] J. Juhasz, J.H. Davis, F.J. Sharom, Fluorescent probe partitioning in giant unilamellar
vesicles of “lipid raft”mixtures, Biochem. J. 430 (2010) 415–423, http://dx.doi.org/
10.1042/BJ20100516.
[114] L.M.S. Loura, M. Prieto, Dehydroergosterol structural organization in aqueous
medium and in a model system of membranes, Biophys. J. 72 (1997)
2226–2236.
[115] K.H. Cheng, J. Virtanen, P. Somerharju, Fluorescence studies of dehydroergosterol
in phosphatidylethanolarnine/phosphatidylcholine bilayers, Biophys. J. 77 (1999)
3108–3119.
[116] J. Lorent, L. Lins, O. Domenech, J. Quetin-Leclercq, R. Brasseur, M.-P. Mingeot-
Leclercq, et al., Domain formation and permeabilization induced by the saponin
α-hederin and its aglycone hederagenin in a cholesterol-containing bilayer, Lang-
muir 30 (2014) 4556–4569, http://dx.doi.org/10.1021/la4049902.
3186 M. Deleu et al. / Biochimica et Biophysica Acta 1838 (2014) 3171–3190[117] I. Jelesarov, H.R. Bosshard, Isothermal titration calorimetry and differential scan-
ning calorimetry as complementary tools to investigate the energetics of biomo-
lecular recognition, J. Mol. Recognit. 12 (1999) 3–18, http://dx.doi.org/10.1002/
(SICI)1099-1352(199901/02)12:1b3::AID-JMR441N3.0.CO;2-6.
[118] H. Heerklotz, J. Seelig, Titration calorimetry of surfactant–membrane partitioning
and membrane solubilization, Biochim. Biophys. Acta Biomembr. 1508 (2000)
69–85, http://dx.doi.org/10.1016/S0304-4157(00)00009-5.
[119] T. Abraham, R.N.A.H. Lewis, R.S. Hodges, R.N. Mc Elhaney, Isothermal titration cal-
orimetry studies of the binding of the antimicrobial peptide gramicidin S to phos-
pholipid bilayer membranes, Biochemistry 44 (2005) 11279–11285.
[120] J. Seelig, Thermodynamics of lipid–peptide interactions, Biochim. Biophys. Acta
1666 (2004) 40–50, http://dx.doi.org/10.1016/j.bbamem.2004.08.004.
[121] R. Ghai, R.J. Falconer, B.M. Collins, Applications of isothermal titration calorimetry
in pure and applied research–survey of the literature from 2010, J. Mol. Recognit.
25 (2012) 32–52, http://dx.doi.org/10.1002/jmr.1167.
[122] H. Heerklotz, The microcalorimetry of lipid membranes, J. Phys. Condens. Matter
16 (2004) R441–R467, http://dx.doi.org/10.1088/0953-8984/16/15/R01.
[123] V. Ball, C. Maechling, Isothermal microcalorimetry to investigate non speciﬁc inter-
actions in biophysical chemistry, Int. J. Mol. Sci. 10 (2009) 3283–3315, http://dx.
doi.org/10.3390/ijms10083283.
[124] P. Draczkowski, D. Matosiuk, K. Jozwiak, Isothermal titration calorimetry in mem-
brane protein research, J. Pharm. Biomed. Anal. 87 (2014) 313–325, http://dx.doi.
org/10.1016/j.jpba.2013.09.003.
[125] G. Machaidze, A. Ziegler, J. Seelig, Speciﬁc binding of Ro 09-0198 (cinnamycin) to
phosphatidylethanolamine: a thermodynamic analysis, Biochemistry 41 (2002)
1965–1971.
[126] C.K. Wang, H.P. Wacklin, D.J. Craik, Cyclotides insert into lipid bilayers to form
membrane pores and destabilize the membrane through hydrophobic and
phosphoethanolamine-speciﬁc interactions, J. Biol. Chem. 287 (2012)
43884–43898, http://dx.doi.org/10.1074/jbc.M112.421198.
[127] G. Henry, M. Deleu, E. Jourdan, P. Thonart, M. Ongena, The bacterial lipopeptide
surfactin targets the lipid fraction of the plant plasma membrane to trigger
immune-related defence responses, Cell. Microbiol. 13 (2011) 1824–1837, http://
dx.doi.org/10.1111/j.1462-5822.2011.01664.x.
[128] D.J. Müller, Y.F. Dufrêne, Atomic force microscopy as a multifunctional molecular
toolbox in nanobiotechnology, Nat. Nanotechnol. 3 (2008) 261–269, http://dx.
doi.org/10.1038/nnano.2008.100.
[129] H.G. Hansma, J.H. Hoh, Biomolecular imaging with the atomic force microscope,
Annu. Rev. Biophys. Biomol. Struct. 23 (1994) 115–139.
[130] C. Möller, M. Allen, V. Elings, A. Engel, D.J. Müller, Tapping-mode atomic force mi-
croscopy produces faithful high-resolution images of protein surfaces, Biophys. J.
77 (1999) 1150–1158.
[131] E. Nagao, J.A. Dvorak, Phase imaging by atomic force microscopy: analysis of living
homoiothermic vertebrate cells, Biophys. J. 76 (1999) 3289–3297.
[132] Y.F. Dufrêne, W.R. Barger, J.B.D. Green, G.U. Lee, Nanometer-scale surface proper-
ties of mixed phospholipid monolayers and bilayers, Langmuir 13 (1997)
4779–4784.
[133] K. El Kirat, S. Morandat, Y.F. Dufrêne, Nanoscale analysis of supported lipid bilayers
using atomic force microscopy, Biochim. Biophys. Acta 1798 (2010) 750–765,
http://dx.doi.org/10.1016/j.bbamem.2009.07.026.
[134] S.B. Lei, R. Tero, N. Misawa, S. Yamamura, L.J. Wan, T. Urisu, AFM characterization of
gramicidin-A in tethered lipid membrane on silicon surface, Chem. Phys. Lett. 429
(2006) 244–249, http://dx.doi.org/10.1016/j.cplett.2006.07.091.
[135] A.P. Quist, A. Chand, S. Ramachandran, C. Daraio, S. Jin, R. Lal, Atomic force micros-
copy imaging and electrical recording of lipid bilayers supported over
microfabricated silicon chip nanopores: lab-on-a-chip system for lipid membranes
and ion channels, Langmuir 23 (2007) 1375–1380, http://dx.doi.org/10.1021/
la062187z.
[136] G. Binnig, C.F. Quate, Atomic force microscope, Phys. Rev. Lett. 56 (1986) 930–933,
http://dx.doi.org/10.1103/PhysRevLett.56.930.
[137] A. Alessandrini, P. Facci, AFM: a versatile tool in biophysics, Meas. Sci. Technol. 16
(2005) R65–R92, http://dx.doi.org/10.1088/0957-0233/16/6/R01.
[138] K. El Kirat, L. Lins, R. Brasseur, Y.F. Dufrêne, Fusogenic tilted peptides induce nano-
scale holes in supported phosphatidylcholine bilayers, Langmuir 21 (2005)
3116–3121, http://dx.doi.org/10.1021/la047640q.
[139] F. Gaboriaud, Y.F. Dufrêne, Atomic force microscopy of microbial cells: application
to nanomechanical properties, surface forces and molecular recognition forces,
Colloids Surf. B: Biointerfaces 54 (2007) 10–19, http://dx.doi.org/10.1016/j.
colsurfb.2006.09.014.
[140] W.F. Heinz, J.H. Hoh, Spatially resolved force spectroscopy of biological surfaces
using the atomic force microscope, Trends Biotechnol. 17 (1999) 143–150,
http://dx.doi.org/10.1016/S0167-7799(99)01304-9.
[141] A. Janshoff, M. Neitzert, Y. Oberdörfer, H. Fuchs, Force spectroscopy of molecular
systems—single molecule spectroscopy of polymers and biomolecules, Angew.
Chem Int. Ed. 39 (2000) 3213–3237.
[142] V. Dupres, F. Menozzi, C. Locht, B. Clare, Nanoscalemapping and functional analysis
of individual adhesins on living bacteria, Nature 2 (2005) 515–521, http://dx.doi.
org/10.1038/NMETH769.
[143] H.-J. Butt, B. Cappella, M. Kappl, Force measurements with the atomic force micro-
scope: technique, interpretation and applications, Surf. Sci. Rep. 59 (2005) 1–152,
http://dx.doi.org/10.1016/j.surfrep.2005.08.003.
[144] Y.F. Dufrêne, P. Hinterdorfer, Recent progress in AFM molecular recognition studies,
Pﬂugers Arch. 456 (2008) 237–245, http://dx.doi.org/10.1007/s00424-007-0413-1.
[145] S. Morandat, S. Azouzi, E. Beauvais, A. Mastouri, K. El Kirat, Atomic force microsco-
py of model lipid membranes, Anal. Bioanal. Chem. 405 (2013) 1445–1461, http://
dx.doi.org/10.1007/s00216-012-6383-y.[146] M. Eeman, M. Deleu, M. Paquot, P. Thonart, Y.F. Dufrêne, Nanoscale properties of
mixed fengycin/ceramide monolayers explored using atomic force microscopy,
Langmuir 21 (2005) 2505–2511, http://dx.doi.org/10.1021/la0475775.
[147] O. Boufﬁoux, A. Berquand, M. Eeman, M. Paquot, Y.F. Dufrêne, R. Brasseur, et al.,
Molecular organization of surfactin-phospholipid monolayers: effect of phospho-
lipid chain length and polar head, Biochim. Biophys. Acta 1768 (2007)
1758–1768, http://dx.doi.org/10.1016/j.bbamem.2007.04.015.
[148] R. Brasseur, M. Deleu, M.-P. Mingeot-Leclercq, G. Francius, Y.F. Dufrêne, Probing
peptide–membrane interactions using AFM, Surf. Interface Anal. 40 (2008)
151–156, http://dx.doi.org/10.1002/sia.2682.
[149] G. Francius, S. Dufour, M. Deleu, M. Paquot, M.-P.P. Mingeot-Leclercq, Y.F. Dufrêne,
Nanoscale membrane activity of surfactins: inﬂuence of geometry, charge and hy-
drophobicity, Biochim. Biophys. Acta Biomembr. 1778 (2008) 2058–2068, http://
dx.doi.org/10.1016/j.bbamem.2008.03.023.
[150] R. Brasseur, N. Braun, K. El Kirat, M. Deleu, M.-P. Mingeot-Leclercq, Y.F. Dufrêne,
The biologically important surfactin lipopeptide induces nanoripples in supported
lipid bilayers, Langmuir 23 (2007) 9769–9772, http://dx.doi.org/10.1021/
la7014868.
[151] D. Tyteca, A. Schanck, Y.F. Dufrêne, M. Deleu, P.J. Courtoy, P.M. Tulkens, et al., The
macrolide antibiotic azithromycin interacts with lipids and affects membrane or-
ganization and ﬂuidity: studies on Langmuir–Blodgett monolayers, liposomes
and J774 macrophages, J. Membr. Biol. 192 (2003) 203–215, http://dx.doi.org/10.
1007/s00232-002-1076-7.
[152] M. Eeman, G. Francius, Y.F. Dufrêne, K. Nott, M. Paquot, M. Deleu, Effect of choles-
terol and fatty acids on the molecular interactions of fengycin with Stratum
corneum mimicking lipid monolayers, Langmuir 25 (2009) 3029–3039, http://
dx.doi.org/10.1021/la803439n.
[153] D. Yamamoto, T. Uchihashi, N. Kodera, H. Yamashita, S. Nishikori, T. Ogura, et al.,
High-speed atomic force microscopy techniques for observing dynamic biomolec-
ular processes, Methods Enzymol. 475 (2010) 541–564, http://dx.doi.org/10.1016/
S0076-6879(10)75020-5.
[154] T.K. Lind, P. Zielińska, H.P. Wacklin, Z. Urbańczyk-Lipkowska, M. Cárdenas, Contin-
uous ﬂow atomic force microscopy imaging reveals ﬂuidity and time-dependent
interactions of antimicrobial dendrimer with model lipid membranes, ACS Nano
8 (2014) 396–408, http://dx.doi.org/10.1021/nn404530z.
[155] P. Hinterdorfer, M.F. Garcia-Parajo, Y.F. Dufrêne, Single-molecule imaging of cell
surfaces using near-ﬁeld nanoscopy, Acc. Chem. Res. 45 (2012) 327–336, http://
dx.doi.org/10.1021/ar2001167.
[156] S. Azouzi, K. El Kirat, S. Morandat, The potent antimalarial drug cyclosporin A pref-
erentially destabilizes sphingomyelin-rich membranes, Langmuir 26 (2010)
1960–1965, http://dx.doi.org/10.1021/la902580w.
[157] K. El Kirat, S. Morandat, Cholesterol modulation of membrane resistance to Triton
X-100 explored by atomic force microscopy, Biochim. Biophys. Acta 1768 (2007)
2300–2309, http://dx.doi.org/10.1016/j.bbamem.2007.05.006.
[158] P.-L. Wu, C.-R. Chiu, W.-N. Huang, W.-G. Wu, The role of sulfatide lipid do-
mains in the membrane pore-forming activity of cobra cardiotoxin, Biochim.
Biophys. Acta 1818 (2012) 1378–1385, http://dx.doi.org/10.1016/j.bbamem.
2012.02.018.
[159] E. Drolle, R.M. Gaikwad, Z. Leonenko, Nanoscale electrostatic domains in
cholesterol-laden lipid membranes create a target for amyloid binding, Biophys.
J. 103 (2012) L27–L29, http://dx.doi.org/10.1016/j.bpj.2012.06.053.
[160] K. Hall, T.-H. Lee, N.L. Daly, D.J. Craik, M.-I. Aguilar, Gly(6) of kalata B1 is critical for
the selective binding to phosphatidylethanolamine membranes, Biochim. Biophys.
Acta 1818 (2012) 2354–2361, http://dx.doi.org/10.1016/j.bbamem.2012.04.007.
[161] M. Deleu, J. Lorent, L. Lins, R. Brasseur, N. Braun, K. El Kirat, et al., Effects of surfactin
on membrane models displaying lipid phase separation, Biochim. Biophys. Acta
Biomembr. 1828 (2013) 801–815, http://dx.doi.org/10.1016/j.bbamem.2012.11.
007.
[162] F. Ott, F. Cousin, A. Menelle, Surfaces and interfaces characterization by neutron re-
ﬂectometry, J. Alloys Compd. 382 (2004) 29–38, http://dx.doi.org/10.1016/j.
jallcom.2004.05.046.
[163] J. Penfold, Neutron reﬂectivity, Langmuir 25 (2009) 3919, http://dx.doi.org/10.
1021/la9003824.
[164] J. Penfold, R.K. Thomas, Neutron reﬂectivity and small angle neutron scattering: an
introduction and perspective on recent progress, Curr. Opin. Colloid Interface Sci.
(2014), http://dx.doi.org/10.1016/j.cocis.2014.01.002.
[165] H.P. Vacklin, F. Tiberg, G. Fragneto, R.K. Thomas, Composition of supported model
membranes determined by neutron reﬂection, Langmuir 21 (2005) 2827–2837,
http://dx.doi.org/10.1021/la047389e.
[166] H.P. Vacklin, F. Tiberg, G. Fragneto, R.K. Thomas, Phospholipase A2 hydrolysis of
supported phospholipid bilayers: a neutron reﬂectivity and ellipsometry study,
Biochemistry 44 (2005) 2811–2821, http://dx.doi.org/10.1021/bi047727a.
[167] G. Fragneto-Cusani, Neutron reﬂectivity at the solid/liquid interface: examples of
applications in biophysics, J. Phys. Condens. Matter 13 (2001) 4973–4989, http://
dx.doi.org/10.1088/0953-8984/13/21/322.
[168] H.-H. Shen, R.K. Thomas, P. Taylor, The location of the biosurfactant surfactin in
phospholipid bilayers supported on silica using neutron reﬂectometry, Langmuir
26 (2010) 320–327, http://dx.doi.org/10.1021/la9034936.
[169] R.V. Stahelin, Surface plasmon resonance: a useful technique for cell biologists to
characterize biomolecular interactions, Mol. Biol. Cell 24 (2013) 883–886.
[170] K. Hall, H. Mozsolits, M.-I. Aguilar, Surface plasmon resonance analysis of antimi-
crobial peptide–membrane interactions: afﬁnity & mechanism of action, Lett.
Pept. Sci. 10 (2003) 475–485, http://dx.doi.org/10.1007/BF02442579.
[171] B. Wiltschi, W. Knoll, E.-K. Sinner, Binding assays with artiﬁcial tethered mem-
branes using surface plasmon resonance, Methods 39 (2006) 134–146, http://dx.
doi.org/10.1016/j.ymeth.2006.05.007.
3187M. Deleu et al. / Biochimica et Biophysica Acta 1838 (2014) 3171–3190[172] V. Hodnik, G. Anderluh, Surface plasmon resonance for measuring interactions of
proteins with lipid membranes, Methods Mol. Biol. 974 (2013) 23–36, http://dx.
doi.org/10.1007/978-1-62703-275-9_2.
[173] J.N. Horn, A. Cravens, A. Grossﬁeld, Interactions between fengycin andmodel bilay-
ers quantiﬁed by coarse-grained molecular dynamics, Biophys. J. 105 (2013)
1612–1623, http://dx.doi.org/10.1016/j.bpj.2013.08.034.
[174] M. Oliveira, O. Franco, J. Nascimento, C. deMelo, C. Andrade, Mechanistic aspects of
peptide–membrane interactions determined by optical, dielectric and piezoelectric
techniques: an overview, Curr. Protein Pept. Sci. 14 (2013) 543–555, http://dx.doi.
org/10.2174/13892037113149990070.
[175] R.A. Espiritu, N.Matsumori,M.Murata, S. Nishimura, H. Kakeya, S.Matsunaga, et al.,
Interaction between the marine sponge cyclic peptide theonellamide A and sterols
in lipid bilayers as viewed by surface plasmon resonance and solid-state (2)H
nuclear magnetic resonance, Biochemistry 52 (2013) 2410–2418, http://dx.doi.
org/10.1021/bi4000854.
[176] M. Gordon-Grossman, H. Zimmermann, S.G. Wolf, Y. Shai, D. Goldfarb, Investiga-
tion of model membrane disruption mechanism by melittin using pulse electron
paramagnetic resonance spectroscopy and cryogenic transmission electron mi-
croscopy, J. Phys. Chem. B 116 (2012) 179–188, http://dx.doi.org/10.1021/
jp207159z.
[177] N. Deo, P. Somasundaran, K. Subramanyan, K.P. Ananthapadmanabhan, Electron
paramagnetic resonance study of the structure of lipid bilayers in the presence of
sodium dodecyl sulfate, J. Colloid Interface Sci. 256 (2002) 100–105, http://dx.
doi.org/10.1006/jcis.2002.8470.
[178] S.A. Dzuba, J. Raap, Spin-echo electron paramagnetic resonance (EPR) spectroscopy
of a pore-forming (Lipo)peptaibol in model and bacterial membranes, Chem.
Biodivers. 10 (2013) 864–875, http://dx.doi.org/10.1002/cbdv.201200387.
[179] D. Yonar, N. Horasan, D.D. Paktaş, Z. Abramović, J. Štrancar, M.M. Sünnetçioğlu,
et al., Interaction of antidepressant drug, clomipramine, with model and biological
stratum corneum membrane as studied by electron paramagnetic resonance, J.
Pharm. Sci. 102 (2013) 3762–3772, http://dx.doi.org/10.1002/jps.23687.
[180] M.F. Ottaviani, R. Daddi, M. Brustolon, N.J. Turro, D.A. Tomalia, Structural modiﬁca-
tions of DMPC vesicles upon interaction with poly(amidoamine) dendrimers stud-
ied by CW-electron paramagnetic resonance and electron spin–echo techniques,
Langmuir 15 (1999) 1973–1980, http://dx.doi.org/10.1021/la9803068.
[181] J. Mizushima, Y. Kawasaki, T. Tabohashi, T. Kitano, K. Sakamoto, M. Kawashima,
et al., Effect of surfactants on human stratum corneum: electron paramagnetic res-
onance study, Int. J. Pharm. 197 (2000) 193–202, http://dx.doi.org/10.1016/S0378-
5173(00)00323-9.
[182] M.L. Kraft, H.A. Klitzing, Imaging lipids with secondary ion mass spectrometry,
Biochim. Biophys. Acta 1841 (2014) 1108–1119.
[183] K.G. Victor, D.S. Caﬁso, Location and dynamics of basic peptides at the membrane
interface: electron paramagnetic resonance spectroscopy of tetramethyl-
piperidine-N-oxyl-4-amino-4-carboxylic acid-labeled peptides, Biophys. J. 81
(2001) 2241–2250.
[184] I.V. Ionova, V.A. Livshits, D. Marsh, Phase diagram of ternary cholesterol/
palmitoylsphingomyelin/palmitoyloleoyl-phosphatidylcholine mixtures: spin-
label EPR study of lipid-raft formation, Biophys. J. 102 (2012) 1856–1865, http://
dx.doi.org/10.1016/j.bpj.2012.03.043.
[185] F.A. Heberle, J. Wu, S.L. Goh, R.S. Petruzielo, G.W. Feigenson, Comparison of three
ternary lipid bilayer mixtures: FRET and ESR reveal nanodomains, Biophys. J. 99
(2010) 3309–3318, http://dx.doi.org/10.1016/j.bpj.2010.09.064.
[186] B. Zhmud, F. Tiberg, Interfacial dynamics and structure of surfactant layers, Adv.
Colloid Interf. Sci. 113 (2005) 21–42, http://dx.doi.org/10.1016/j.cis.2005.01.001.
[187] M. Deleu, M. Paquot, T. Nylander, Effect of fengycin, a lipopeptide produced by Ba-
cillus subtilis, onmodel biomembranes, Biophys. J. 94 (2008) 2667–2679, http://dx.
doi.org/10.1529/biophysj.107.114090.
[188] R.P. Richter, A.R. Brisson, Following the formation of supported lipid bilayers on
mica: a study combining AFM, QCM-D, and ellipsometry, Biophys. J. 88 (2005)
3422–3433, http://dx.doi.org/10.1529/biophysj.104.053728.
[189] R. Machán, A. Miszta, W. Hermens, M. Hof, Real-time monitoring of melittin-
induced pore and tubule formation from supported lipid bilayers and its physio-
logical relevance, Chem. Phys. Lipids 163 (2010) 200–206, http://dx.doi.org/10.
1016/j.chemphyslip.2009.11.005.
[190] M.C. Howland, A.W. Szmodis, B. Sanii, A.N. Parikh, Characterization of physical
properties of supported phospholipid membranes using imaging ellipsometry at
optical wavelengths, Biophys. J. 92 (2007) 1306–1317, http://dx.doi.org/10.1529/
biophysj.106.097071.
[191] D. Choi, J.H. Moon, H. Kim, B.J. Sung, M.W. Kim, G.Y. Tae, et al., Insertionmechanism
of cell-penetrating peptides into supported phospholipid membranes revealed by
X-ray and neutron reﬂection, Soft Matter 8 (2012) 8294, http://dx.doi.org/10.
1039/c2sm25913c.
[192] C. Li, D. Constantin, T. Salditt, Biomimetic membranes of lipid–peptide model sys-
tems prepared on solid support, J. Phys. Condens. Matter 16 (2004) S2439–S2453,
http://dx.doi.org/10.1088/0953-8984/16/26/017.
[193] G. Fragneto, E. Bellet-Amalric, T. Charitat, P. Dubos, F. Graner, L. Perino-Galice, Neu-
tron and X-ray reﬂectivity studies at solid–liquid interfaces: the interaction of a
peptide with model membranes, Phys. B Condens. Matter 276–278 (2000)
501–502, http://dx.doi.org/10.1016/S0921-4526(99)01823-2.
[194] T. Buffeteau, B. Desbat, J.M. Turlet, Polarization modulation FT-IR spectroscopy of
surfaces and ultra-thin ﬁlms: experimental procedure and quantitative analysis,
Appl. Spectrosc. 45 (1991) 380–389.
[195] E. Goormaghtigh, V. Raussens, J.-M. Ruysschaert, Attenuated total reﬂection infra-
red spectroscopy of proteins and lipids in biological membranes, Biochim. Biophys.
Acta Rev. Biomembr. 1422 (1999) 105–185, http://dx.doi.org/10.1016/S0304-
4157(99)00004-0.[196] J. Kong, S. Yu, Fourier transform infrared spectroscopic analysis of protein second-
ary structures, Acta Biochim. Biophys. Sin. (Shanghai) 39 (2007) 549–559, http://
dx.doi.org/10.1111/j.1745-7270.2007.00320.x.
[197] K. Roodenko, D. Aureau, F. Yang, P. Thissen, J. Rappich, Ellipsometry of Functional
Organic Surfaces and Films, Springer Berlin Heidelberg, Berlin, Heidelberg, 2014.,
http://dx.doi.org/10.1007/978-3-642-40128-2.
[198] L.K. TAMM, S.A. TATULIAN, Infrared spectroscopy of proteins and peptides in lipid
bilayers, Q. Rev. Biophys. 30 (1997) 365–429.
[199] J.L.R. Arrondo, F.M. Goñi, Infrared studies of protein-induced perturbation of lipids
in lipoproteins andmembranes, Chem. Phys. Lipids 96 (1998) 53–68, http://dx.doi.
org/10.1016/S0009-3084(98)00080-2.
[200] L. Ter-Minassian-Saraga, E. Okamura, J. Umemura, T. Takenaka, Fourier
transform infrared-attenuated total reﬂection spectroscopy of hydration of
dimyristoylphosphatidylcholine multibilayers, Biochim. Biophys. Acta
Biomembr. 946 (1988) 417–423, http://dx.doi.org/10.1016/0005-2736(88)
90417-8.
[201] R.D. Herculano, F.J. Pavinatto, L. Caseli, C. D'Silva, O.N. Oliveira, The lipid composi-
tion of a cell membrane modulates the interaction of an antiparasitic peptide at
the air–water interface, Biochim. Biophys. Acta 1808 (2011) 1907–1912, http://
dx.doi.org/10.1016/j.bbamem.2011.03.012.
[202] C.P. Pascholati, E.P. Lopera, F.J. Pavinatto, L. Caseli, T.M. Nobre, M.E.D. Zaniquelli,
et al., The interaction of an antiparasitic peptide active against African sleeping
sickness with cell membrane models, Colloids Surf. B: Biointerfaces 74 (2009)
504–510, http://dx.doi.org/10.1016/j.colsurfb.2009.08.018.
[203] C. Loison, M.N. Nasir, E. Benichou, F. Besson, P.-F. Brevet, Multi-scale modeling of
mycosubtilin lipopeptides at the air/water interface: structure and optical second
harmonic generation, Phys. Chem. Chem. Phys. 16 (2014) 2136–2148, http://dx.
doi.org/10.1039/c3cp53101e.
[204] M.N. Nasir, F. Besson, M. Deleu, Interactions des antibiotiques ituriniques avec la
membrane plasmique. Apport des systèmes biomimétiques des membranes (Syn-
thèse bibliographique), Biotechnol. Agron. Soc. Environ. 17 (2013) 505–516.
[205] M.N. Nasir, V. Legrand, S. Gatard, S. Bouquillon, K. Nott, L. Lins, et al., Physico-
chemical and membrane-interacting properties of D-xylose-based bolaforms, In-
ﬂuence of the anomeric conﬁguration, MATEC Web Conf., 4, 2013, p. 04003,
http://dx.doi.org/10.1051/matecconf/20130404003.
[206] M.N. Nasir, E. Benichou, C. Loison, I. Russier-Antoine, F. Besson, P.-F. Brevet, Inﬂu-
ence of the tyrosine environment on the second harmonic generation of iturinic
antimicrobial lipopeptides at the air–water interface, Phys. Chem. Chem. Phys. 15
(2013) 19919–19924, http://dx.doi.org/10.1039/c3cp53098a.
[207] M.N. Nasir, E. Benichou, J.S. Guez, P. Jacques, P.-F. Brevet, F. Besson, Second har-
monic generation to monitor the interactions of the antimicrobial mycosubtilin
with membrane-mimicking interfacial monolayers, Biogeosciences 2 (2012)
108–112, http://dx.doi.org/10.1007/s12668-012-0037-6.
[208] F. Besson, M.J. Quentin, G. Michel, Action of mycosubtilin on erythrocytes and arti-
ﬁcial membranes, Microbios 59 (1989) 137–143.
[209] N. Izumiya, Synthetic aspects of biologically active cyclic peptides: gramicidin S
and tyrocidines, 1979.
[210] H. Kleinkauf, H. von Döhren, Biochemistry of peptide antibiotics: recent advances
in the biotechnology of B-lactams and microbial bioactive peptides, 1990.
[211] E.J. Prenner, R.N.A.H. Lewis, M. Jelokhani-Niaraki, R.S. Hodges, R.N. McElhaney,
Cholesterol attenuates the interaction of the antimicrobial peptide gramicidin S
with phospholipid bilayer membranes, Biochim. Biophys. Acta Biomembr. 1510
(2001) 83–92, http://dx.doi.org/10.1016/S0005-2736(00)00337-0.
[212] R.N.A.H. Lewis, M. Kiricsi, E.J. Prenner, R.S. Hodges, R.N. McElhaney, Fourier trans-
form infrared spectroscopic study of the interactions of a strongly antimicrobial
but weakly hemolytic analogue of gramicidin S with lipid micelles and lipid bilayer
membranes, Biochemistry 42 (2003) 440–449, http://dx.doi.org/10.1021/
bi026707a.
[213] I. Martin, F. Defrise-Quertain, V. Mandieau, N.M. Nielsen, T. Saermark, A. Burny,
et al., Fusogenic activity of SIV (Simian Immunodeﬁciency Virus) peptides located
in the GP32 NH2 terminal domain, Biochem. Biophys. Res. Commun. 175 (1991)
872–879, http://dx.doi.org/10.1016/0006-291X(91)91646-T.
[214] L. Lins, R. Brasseur, M. Rosseneu, C.Y. Yang, D.A. Sparrow, J.T. Sparrow, et al., Struc-
ture and orientation of apo B-100 peptides into a lipid bilayer, J. Protein Chem. 13
(1994) 77–88.
[215] A. Grelard, A. Couvreux, C. Loudet, E.J. Dufourc, Solution and solid-state NMR of
lipids, Methods Mol. Biol. 462 (2009) 111–133.
[216] A. Grélard, C. Loudet, A. Diller, E.J. Dufourc, NMR spectroscopy of lipid bilayers,
Methods Mol. Biol. 654 (2010) 341–359, http://dx.doi.org/10.1007/978-1-60761-
762-4_18.
[217] M.P. Mingeot-Leclercq, R. Brasseur, A. Schanck, Molecular parameters involved in
aminoglycoside nephrotoxicity, J. Toxicol. Environ. Health 44 (1995) 263–300,
http://dx.doi.org/10.1080/15287399509531960.
[218] R. Mingeot-Leclercq, Marie-Paule Schanck, Andre Van Bambeke, Francoise
Lins, Laurence Brasseur, Molecular description of the interactions of amino-
glycoside antibiotics with negatively-charged phospholipids. Theoretical mo-
lecular modelling and experimental results, Pharmacology 14 (1995) 71–98
(Life Sci. Adv.).
[219] J. Barry, M. Fritz, J.R. Brender, P.E.S. Smith, D.-K. Lee, A. Ramamoorthy, Determining
the effects of lipophilic drugs on membrane structure by solid-state NMR spectros-
copy: the case of the antioxidant curcumin, J. Am. Chem. Soc. 131 (2009)
4490–4498, http://dx.doi.org/10.1021/ja809217u.
[220] D.E. Warschawski, A.A. Arnold, M. Beaugrand, A. Gravel, É. Chartrand, I. Marcotte,
Choosing membrane mimetics for NMR structural studies of transmembrane pro-
teins, Biochim. Biophys. Acta 1808 (2011) 1957–1974, http://dx.doi.org/10.1016/j.
bbamem.2011.03.016.
3188 M. Deleu et al. / Biochimica et Biophysica Acta 1838 (2014) 3171–3190[221] D.A. Kallick, M.R. Tessmer, C.R. Watts, C.Y. Li, The use of dodecylphosphocholine
micelles in solution NMR, J. Magn. Reson. Ser. B 109 (1995) 60–65, http://dx.doi.
org/10.1006/jmrb.1995.1146.
[222] R.S. Prosser, F. Evanics, J.L. Kitevski, M.S. Al-Abdul-Wahid, Current applica-
tions of bicelles in NMR studies of membrane-associated amphiphiles and
proteins, Biochemistry 45 (2006) 8453–8465, http://dx.doi.org/10.1021/
bi060615u.
[223] S.G. Boxer, M.L. Kraft, P.K. Weber, Advances in imaging secondary ion mass spec-
trometry for biological samples, Annu. Rev. Biophys. 38 (2009) 53–74, http://dx.
doi.org/10.1146/annurev.biophys.050708.133634.
[224] I. Gözen, A. Jesorka, Instrumental methods to characterize molecular phospholipid
ﬁlms on solid supports, Anal. Chem. 84 (2012) 822–838, http://dx.doi.org/10.1021/
ac203126f.
[225] M. Lozano, Z. Liu, E. Sunnick, A. Janshoff, K. Kumar, S.G. Boxer, Colocalization of the
ganglioside GM1 and cholesterol detected by secondary ion mass spectrometry, J.
Am. Chem. Soc. 135 (2013) 5620–5630.
[226] R. Harkewicz, E.A. Dennis, Applications of mass spectrometry to lipids and mem-
branes, Annu. Rev. Biochem. 80 (2011) 301–325.
[227] C.M. McQuaw, L. Zheng, A.G. Ewing, N. Winograd, Localization of sphingomyelin in
cholesterol domains by imaging mass spectrometry, Langmuir 23 (2007)
5645–5650, http://dx.doi.org/10.1021/la063251f.
[228] M.L. Kraft, P.K. Weber, M.L. Longo, I.D. Hutcheon, S.G. Boxer, Phase separation
of lipid membranes analyzed with high-resolution secondary ion mass spec-
trometry, Science 313 (2006) 1948–1951, http://dx.doi.org/10.1126/science.
1130279.
[229] C.R. Anderton, K. Lou, P.K. Weber, I.D. Hutcheon, M.L. Kraft, Correlated AFM and
NanoSIMS imaging to probe cholesterol-induced changes in phase behavior and
non-ideal mixing in ternary lipid membranes, Biochim. Biophys. Acta 1808
(2011) 307–315, http://dx.doi.org/10.1016/j.bbamem.2010.09.016.
[230] K. Kita-Tokarczyk, F. Itel, M. Grzelakowski, S. Egli, P. Rossbach, W. Meier, Monolay-
er interactions between lipids and amphiphilic block copolymers, Langmuir 25
(2009) 9847–9856, http://dx.doi.org/10.1021/la900948a.
[231] M. Saleem, M.C. Meyer, D. Breitenstein, H.-J. Galla, The surfactant peptide KL4 in
lipid monolayers: phase behavior, topography, and chemical distribution, J. Biol.
Chem. 283 (2008) 5195–5207, http://dx.doi.org/10.1074/jbc.M705944200.
[232] P. Rakowska, H. Jiang, S. Ray, A. Pyne, B. Lamarre, M. Carr, et al., Nanoscale imaging
reveals laterally expanding antimicrobial pores in lipid bilayers, PNAS 110 (2013)
8918–8923, http://dx.doi.org/10.1073/pnas.1222824110/-/DCSupplemental.www.
pnas.org/cgi/doi/10.1073/pnas.1222824110.
[233] L. Yang, X.-Y. Yu, Z. Zhu, M.J. Iedema, J.P. Cowin, Probing liquid surfaces under vac-
uum using SEM and ToF-SIMS, Lab Chip 11 (2011) 2481–2484, http://dx.doi.org/
10.1039/c0lc00676a.
[234] L. Lins, A. Thomas-Soumarmon, T. Pillot, J. Vandekerckhove, M. Rosseneu, R.
Brasseur, Molecular determinants of the interaction between the c-terminal do-
main of Alzheimer's β-amyloid peptide and apolipoprotein E α-helices, J.
Neurochem. 73 (1999) 758–769, http://dx.doi.org/10.1046/j.1471-4159.1999.
0730758.x.
[235] R. Brasseur, J.A. Killian, B. De Kruijff, J.M. Ruysschaert, Conformational analysis of
gramicidin–gramicidin interactions at the air/water interface suggests that grami-
cidin aggregates into tube-like structures similar as found in the gramicidin-
induced hexagonal HII phase, Biochim. Biophys. Acta 903 (1987) 11–17.
[236] L. Lins, R. Brasseur, The hydrophobic effect in protein folding, FASEB J. 9 (1995)
535–540, http://dx.doi.org/10.1042/BJ20100615.
[237] H. Razaﬁndralambo, C. Blecker, S. Mezdour, C. Deroanne, J.-M. Crowet, R. Brasseur,
et al., Impacts of the carbonyl group location of ester bond on interfacial properties
of sugar-based surfactants: experimental and computational evidences, J. Phys.
Chem. B 113 (2009) 8872–8877, http://dx.doi.org/10.1021/jp903187f.
[238] X. Gallet, M. Deleu, H. Razaﬁndralambo, P. Jacques, P. Thonart, M. Paquot, et al.,
Computer simulation of surfactin conformation at a hydrophobic/hydrophilic in-
terface, Langmuir 15 (1999) 2409–2413.
[239] F. Nsimba Zakanda, L. Lins, K. Nott, M. Paquot, G. Mvumbi Lelo, M. Deleu, Interac-
tion of hexadecylbetainate chloride with biological relevant lipids, Langmuir 28
(2012) 3524–3533, http://dx.doi.org/10.1021/la2040328.
[240] M.-P. Mingeot-Leclercq, L. Lins, M. Bensliman, A. Thomas, F. Van Bambeke, J.
Peuvot, et al., Piracetam inhibits the lipid-destabilising effect of the amyloid pep-
tide Abeta C-terminal fragment, Biochim. Biophys. Acta 1609 (2003) 28–38.
[241] J. Fantini, D. Carlus, N. Yahi, The fusogenic tilted peptide (67–78) of α-synuclein is
a cholesterol binding domain, Biochim. Biophys. Acta 1808 (2011) 2343–2351,
http://dx.doi.org/10.1016/j.bbamem.2011.06.017.
[242] J. Fantini, F.J. Barrantes, How cholesterol interacts with membrane proteins: an ex-
ploration of cholesterol-binding sites including CRAC, CARC, and tilted domains,
Front. Physiol. 4 (2013) 31, http://dx.doi.org/10.3389/fphys.2013.00031.
[243] L. Lins, M. Decaffmeyer, A. Thomas, R. Brasseur, Relationships between the orienta-
tion and the structural properties of peptides and their membrane interactions,
Biochim. Biophys. Acta 1778 (2008) 1537–1544.
[244] J. Crowet, L. Lins, I. Dupiereux, B. Elmoualija, A. Lorin, B. Charloteaux, et al., Tilted
properties of the 67–78 fragment of alpha-synuclein are responsible for membrane
destabilization and neurotoxicity, Proteins 68 (2007) 936–947, http://dx.doi.org/
10.1002/prot.21483.
[245] L. Lins, B. Charloteaux, C. Heinen, A. Thomas, R. Brasseur, “De novo” design of pep-
tides with speciﬁc lipid-binding properties, Biophys. J. 90 (2006) 470–479.
[246] L. Lins, B. Charloteaux, A. Thomas, R. Brasseur, Computational study of lipid-
destabilizing protein fragments: towards a comprehensive view of tilted peptides,
Proteins 44 (2001) 435–447.
[247] A.P. Lyubartsev, A.L. Rabinovich, Recent development in computer simulations of
lipid bilayers, Soft Matter 7 (2011) 25, http://dx.doi.org/10.1039/c0sm00457j.[248] P. Bjelkmar, P.S. Niemelä, I. Vattulainen, E. Lindahl, Conformational changes and
slow dynamics through microsecond polarized atomistic molecular simulation of
an integral Kv1.2 ion channel, PLoS Comput. Biol. 5 (2009) e1000289.
[249] W.F.D. Bennett, D.P. Tieleman, Computer simulations of lipid membrane domains,
Biochim. Biophys. Acta 1828 (2013) 1765–1776, http://dx.doi.org/10.1016/j.
bbamem.2013.03.004.
[250] J.C. Shelley, M.Y. Shelley, R.C. Reeder, S. Bandyopadhyay, M.L. Klein, A coarse grain
model for phospholipid simulations, J. Phys. Chem. B 105 (2001) 4464–4470,
http://dx.doi.org/10.1021/jp010238p.
[251] S.J. Marrink, A.H. de Vries, A.E. Mark, Coarse grained model for semiquantitative
lipid simulations, J. Phys. Chem. B 108 (2004) 750–760, http://dx.doi.org/10.
1021/jp036508g.
[252] M. Orsi, J.W. Essex, The ELBA force ﬁeld for coarse-grain modeling of lipid mem-
branes, PLoS One 6 (2011) e28637, http://dx.doi.org/10.1371/journal.pone.
0028637.
[253] L. Monticelli, S.K. Kandasamy, X. Periole, R.G. Larson, D.P. Tieleman, S. Marrink, The
MARTINI coarse-grained force ﬁeld: extension to proteins, J. Chem. Theory
Comput. 4 (2008) 819–834, http://dx.doi.org/10.1021/ct700324x.
[254] C.A. López, A.J. Rzepiela, A.H. de Vries, L. Dijkhuizen, P.H. Hünenberger, S.J. Marrink,
Martini coarse-grained force ﬁeld: extension to carbohydrates, J. Chem. Theory
Comput. 5 (2009) 3195–3210, http://dx.doi.org/10.1021/ct900313w.
[255] H.J. Risselada, S.J. Marrink, The molecular face of lipid rafts in model membranes,
Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 17367–17372, http://dx.doi.org/10.1073/
pnas.0807527105.
[256] H.J. Risselada, C. Kutzner, H. Grubmüller, Caught in the act: visualization of SNARE-
mediated fusion events in molecular detail, Chembiochem 12 (2011) 1049–1055,
http://dx.doi.org/10.1002/cbic.201100020.
[257] S. Baoukina, D.P. Tieleman, Lung surfactant protein SP-B promotes formation of bi-
layer reservoirs from monolayer and lipid transfer between the interface and sub-
phase, Biophys. J. 100 (2011) 1678–1687, http://dx.doi.org/10.1016/j.bpj.2011.02.
019.
[258] S. Jalili, M. Akhavan, A coarse-grained molecular dynamics simulation of a sodium
dodecyl sulfate micelle in aqueous solution, Colloids Surf. A Physicochem. Eng. Asp.
352 (2009) 99–102, http://dx.doi.org/10.1016/j.colsurfa.2009.10.007.
[259] J.F. Kraft, M. Vestergaard, B. Schiøtt, L. Thøgersen, Modeling the self-assembly and
stability of DHPC micelles using atomic resolution and coarse grained MD simula-
tions, J. Chem. Theory Comput. 8 (2012) 1556–1569, http://dx.doi.org/10.1021/
ct200921u.
[260] X. Periole, T. Huber, S.-J. Marrink, T.P. Sakmar, G protein-coupled receptors self-
assemble in dynamics simulations of model bilayers, J. Am. Chem. Soc. 129
(2007) 10126–10132, http://dx.doi.org/10.1021/ja0706246.
[261] B.R. Brooks, C.L. Brooks, A.D. Mackerell, L. Nilsson, R.J. Petrella, B. Roux, et al.,
CHARMM: the biomolecular simulation program, J. Comput. Chem. 30 (2009)
1545–1614, http://dx.doi.org/10.1002/jcc.21287.
[262] J.B. Klauda, V. Monje, T. Kim,W. Im, Improving the CHARMM force ﬁeld for polyun-
saturated fatty acid chains, J. Phys. Chem. B 116 (2012) 9424–9431, http://dx.doi.
org/10.1021/jp304056p.
[263] J.B. Lim, B. Rogaski, J.B. Klauda, Update of the cholesterol force ﬁeld parameters in
CHARMM, J. Phys. Chem. B 116 (2012) 203–210, http://dx.doi.org/10.1021/
jp207925m.
[264] B. Jójárt, T.A. Martinek, Performance of the general amber force ﬁeld in modeling
aqueous POPC membrane bilayers, J. Comput. Chem. 28 (2007) 2051–2058,
http://dx.doi.org/10.1002/jcc.20748.
[265] C.J. Dickson, L. Rosso, R.M. Betz, R.C. Walker, I.R. Gould, GAFFlipid: a General Amber
Force Field for the accurate molecular dynamics simulation of phospholipid, Soft
Matter 8 (2012) 9617, http://dx.doi.org/10.1039/c2sm26007g.
[266] J.P.M. Jämbeck, A.P. Lyubartsev, Derivation and systematic validation of a reﬁned
all-atom force ﬁeld for phosphatidylcholine lipids, J. Phys. Chem. B 116 (2012)
3164–3179, http://dx.doi.org/10.1021/jp212503e.
[267] J.P.M. Jämbeck, A.P. Lyubartsev, Another piece of the membrane puzzle: extending
slipids further, J. Chem. Theory Comput. 9 (2013) 774–784, http://dx.doi.org/10.
1021/ct300777p.
[268] E. Lindahl, B. Hess, D. Van Der Spoel, GROMACS 3.0: a package for molecular sim-
ulation and trajectory analysis, Mol. Model. Annu. 7 (2001) 306–317, http://dx.doi.
org/10.1007/s008940100045.
[269] O. Berger, O. Edholm, F. Jähnig, Molecular dynamics simulations of a ﬂuid bilayer of
dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant
temperature, Biophys. J. 72 (1997) 2002–2013, http://dx.doi.org/10.1016/S0006-
3495(97)78845-3.
[270] M. Höltje, T. Förster, B. Brandt, T. Engels, W. von Rybinski, H.-D. Höltje, Molecular
dynamics simulations of stratum corneum lipid models: fatty acids and cholester-
ol, Biochim. Biophys. Acta Biomembr. 1511 (2001) 156–167, http://dx.doi.org/10.
1016/S0005-2736(01)00270-X.
[271] P.S. Niemelä, S. Ollila, M.T. Hyvönen, M. Karttunen, I. Vattulainen, Assessing the na-
ture of lipid raft membranes, PLoS Comput. Biol. 3 (2007) e34, http://dx.doi.org/10.
1371/journal.pcbi.0030034.
[272] D.P. Tieleman, H.J. Berendsen, A molecular dynamics study of the pores formed by
Escherichia coliOmpF porin in a fully hydrated palmitoyloleoylphosphatidylcholine
bilayer, Biophys. J. 74 (1998) 2786–2801, http://dx.doi.org/10.1016/S0006-
3495(98)77986-X.
[273] S.-W. Chiu, S.A. Pandit, H.L. Scott, E. Jakobsson, An improved united atom force ﬁeld
for simulation of mixed lipid bilayers, J. Phys. Chem. B 113 (2009) 2748–2763.
[274] D.A. Holdbrook, Y.M. Leung, T.J. Piggot, P. Marius, P.T.F. Williamson, S. Khalid, Sta-
bility and membrane orientation of the fukutin transmembrane domain: a com-
bined multiscale molecular dynamics and circular dichroism study, Biochemistry
49 (2010) 10796–10802, http://dx.doi.org/10.1021/bi101743w.
3189M. Deleu et al. / Biochimica et Biophysica Acta 1838 (2014) 3171–3190[275] T.J. Piggot, D.A. Holdbrook, S. Khalid, Electroporation of the E. coli and S. aureus
membranes: molecular dynamics simulations of complex bacterial membranes, J.
Phys. Chem. B 115 (2011) 13381–13388.
[276] T.J. Piggot, Á. Piñeiro, S. Khalid, Molecular dynamics simulations of phosphatidyl-
choline membranes: a comparative force ﬁeld study, J. Chem. Theory Comput. 8
(2012) 4593–4609, http://dx.doi.org/10.1021/ct3003157.
[277] A. Kukol, Lipid models for united-atom molecular dynamics simulations of pro-
teins, J. Chem. Theory Comput. 5 (2009) 615–626, http://dx.doi.org/10.1021/
ct8003468.
[278] D. Poger, A.E. Mark, Lipid bilayers: the effect of force ﬁeld on ordering and dynam-
ics, J. Chem. Theory Comput. 8 (2012) 4807–4817, http://dx.doi.org/10.1021/
ct300675z.
[279] J.P. Ulmschneider, M.B. Ulmschneider, United atom lipid parameters for com-
bination with the optimized potentials for liquid simulations all-atom force
ﬁeld, J. Chem. Theory Comput. 5 (2009) 1803–1813, http://dx.doi.org/10.
1021/ct900086b.
[280] S. Baoukina, L. Monticelli, M. Amrein, D.P. Tieleman, The molecular mechanism of
monolayer-bilayer transformations of lung surfactant from molecular dynamics
simulations, Biophys. J. 93 (2007) 3775–3782, http://dx.doi.org/10.1529/biophysj.
107.113399.
[281] M. Dahlberg, A. Maliniak, Mechanical properties of coarse-grained bilayers formed
by cardiolipin and zwitterionic lipids, J. Chem. Theory Comput. 6 (2010)
1638–1649, http://dx.doi.org/10.1021/ct900654e.
[282] S.J. Marrink, A.H. de Vries, T.A. Harroun, J. Katsaras, S.R. Wassall, Cholesterol shows
preference for the interior of polyunsaturated lipid membranes, J. Am. Chem. Soc.
130 (2008) 10–11, http://dx.doi.org/10.1021/ja076641c.
[283] S.J. Marrink, H.J. Risselada, S. Yeﬁmov, D.P. Tieleman, A.H. de Vries, The MARTINI
force ﬁeld: coarse grained model for biomolecular simulations, J. Phys. Chem. B
111 (2007) 7812–7824, http://dx.doi.org/10.1021/jp071097f.
[284] K.A. Scott, P.J. Bond, A. Ivetac, A.P. Chetwynd, S. Khalid, M.S.P. Sansom, Coarse-
grained MD simulations of membrane protein-bilayer self-assembly, Structure 16
(2008) 621–630, http://dx.doi.org/10.1016/j.str.2008.01.014.
[285] C.L. Wee, D. Gavaghan, M.S.P. Sansom, Lipid bilayer deformation and the free ener-
gy of interaction of a Kv channel gating-modiﬁer toxin, Biophys. J. 95 (2008)
3816–3826, http://dx.doi.org/10.1529/biophysj.108.130971.
[286] L. Kalé, R. Skeel, M. Bhandarkar, R. Brunner, A. Gursoy, N. Krawetz, et al., NAMD2:
greater scalability for parallel molecular dynamics, J. Comput. Phys. 151 (1999)
283–312, http://dx.doi.org/10.1006/jcph.1999.6201.
[287] D. Poger, A.E. Mark, On the validation of molecular dynamics simulations of satu-
rated and cis-monounsaturated phosphatidylcholine lipid bilayers: a comparison
with experiment, J. Chem. Theory Comput. 6 (2010) 325–336, http://dx.doi.org/
10.1021/ct900487a.
[288] D. Poger, W.F. Van Gunsteren, A.E. Mark, A new force ﬁeld for simulating phospha-
tidylcholine bilayers, J. Comput. Chem. 31 (2010) 1117–1125, http://dx.doi.org/10.
1002/jcc.21396.
[289] I. Chandrasekhar, M. Kastenholz, R.D. Lins, C. Oostenbrink, L.D. Schuler, D.P.
Tieleman, et al., A consistent potential energy parameter set for lipids:
dipalmitoylphosphatidylcholine as a benchmark of the GROMOS96 45A3 force
ﬁeld, Eur. Biophys. J. 32 (2003) 67–77, http://dx.doi.org/10.1007/s00249-002-
0269-4.
[290] J.B. Klauda, R.M. Venable, J.A. Freites, J.W. O'Connor, D.J. Tobias, C. Mondragon-
Ramirez, et al., Update of the CHARMM all-atom additive force ﬁeld for lipids: val-
idation on six lipid types, J. Phys. Chem. B 114 (2010) 7830–7843, http://dx.doi.
org/10.1021/jp101759q.
[291] R.W. Benz, F. Castro-Román, D.J. Tobias, S.H. White, Experimental validation of mo-
lecular dynamics simulations of lipid bilayers: a new approach, Biophys. J. 88
(2005) 805–817, http://dx.doi.org/10.1529/biophysj.104.046821.
[292] A.K. Malde, L. Zuo, M. Breeze, M. Stroet, D. Poger, P.C. Nair, et al., An automated
force ﬁeld topology builder (ATB) and repository: version 1.0, J. Chem. Theory
Comput. 7 (2011) 4026–4037, http://dx.doi.org/10.1021/ct200196m.
[293] J. Domański, P.J. Stansfeld, M.S.P. Sansom, O. Beckstein, Lipidbook: a public reposi-
tory for force-ﬁeld parameters used in membrane simulations, J. Membr. Biol. 236
(2010) 255–258, http://dx.doi.org/10.1007/s00232-010-9296-8.
[294] S.E. Feller, A.D. MacKerell, An improved empirical potential energy function for
molecular simulations of phospholipids, J. Phys. Chem. B 104 (2000) 7510–7515.
[295] S. Jo, T. Kim, W. Im, Automated builder and database of protein/membrane com-
plexes for molecular dynamics simulations, PLoS One 2 (2007) e880, http://dx.
doi.org/10.1371/journal.pone.0000880.
[296] N. Dony, J.M. Crowet, B. Joris, R. Brasseur, L. Lins, SAHBNET, an accessible surface-
based elastic network: an application to membrane protein, Int. J. Mol. Sci. 14
(2013) 11510–11526, http://dx.doi.org/10.3390/ijms140611510.
[297] M.M. Ghahremanpour, S.S. Arab, S.B. Aghazadeh, J. Zhang, D. van der Spoel,
MemBuilder: a web-based graphical interface to build heterogeneously
mixed membrane bilayers for the GROMACS biomolecular simulation pro-
gram, Bioinformatics 30 (2014) 439–441, http://dx.doi.org/10.1093/bioinfor-
matics/btt680.
[298] S. Jo, J.B. Lim, J.B. Klauda, W. Im, CHARMM-GUI membrane builder for mixed bilay-
ers and its application to yeast membranes, Biophys. J. 97 (2009) 50–58, http://dx.
doi.org/10.1016/j.bpj.2009.04.013.
[299] B. Sommer, T. Dingersen, C. Gamroth, S.E. Schneider, S. Rubert, J. Krüger, et al.,
CELLmicrocosmos 2.2 MembraneEditor: a modular interactive shape-based soft-
ware approach to solve heterogeneous membrane packing problems, J. Chem.
Inf. Model. (2011) 1165–1182, http://dx.doi.org/10.1021/ci1003619.
[300] J.-M. Crowet, D.L. Parton, B.A. Hall, S. Steinhauer, R. Brasseur, L. Lins, et al., Multi-
scale simulation of the simian immunodeﬁciency virus fusion peptide, J. Phys.
Chem. B 116 (2012) 13713–13721.[301] P.J. Bond, M.S.P. Sansom, Insertion and assembly of membrane proteins via
simulation, J. Am. Chem. Soc. 128 (2006) 2697–2704, http://dx.doi.org/10.
1021/ja0569104.
[302] M.G. Wolf, M. Hoeﬂing, C. Aponte-Santamaría, H. Grubmüller, G. Groenhof, g_
membed: efﬁcient insertion of a membrane protein into an equilibrated lipid bi-
layer with minimal perturbation, J. Comput. Chem. 31 (2010) 2169–2174, http://
dx.doi.org/10.1002/jcc.21507.
[303] C. Kandt,W.L. Ash, D.P. Tieleman, Setting up and running molecular dynamics sim-
ulations of membrane proteins, Methods 41 (2007) 475–488, http://dx.doi.org/10.
1016/j.ymeth.2006.08.006.
[304] P. Gkeka, L. Sarkisov, Interactions of phospholipid bilayers with several classes of
amphiphilic alpha-helical peptides: insights from coarse-grained molecular dy-
namics simulations, J. Phys. Chem. B 114 (2010) 826–839, http://dx.doi.org/10.
1021/jp908320b.
[305] V.V. Vostrikov, B.A. Hall, D.V. Greathouse, R.E. Koeppe, M.S.P. Sansom, Changes in
transmembrane helix alignment by arginine residues revealed by solid-state
NMR experiments and coarse-grained MD simulations, J. Am. Chem. Soc. 132
(2010) 5803–5811, http://dx.doi.org/10.1021/ja100598e.
[306] M.F. Lensink, B. Christiaens, J. Vandekerckhove, A. Prochiantz, M. Rosseneu,
Penetratin-membrane association: W48/R52/W56 shield the peptide from the
aqueous phase, Biophys. J. 88 (2005) 939–952, http://dx.doi.org/10.1529/
biophysj.104.052787.
[307] M.F. Martini, M. Pickholz, Molecular dynamics study of uncharged bupivacaine en-
antiomers in phospholipid bilayers, Int. J. Quantum Chem. 112 (2012) 3341–3345,
http://dx.doi.org/10.1002/qua.24208.
[308] W. Kopeć, J. Telenius, H. Khandelia, Molecular dynamics simulations of the interac-
tions of medicinal plant extracts and drugs with lipid bilayer membranes, FEBS J.
280 (2013) 2785–2805, http://dx.doi.org/10.1111/febs.12286.
[309] M. Manna, T. Rog, I. Vattulainen, The challenges of understanding glycolipid func-
tions: an open outlook based on molecular simulations, Biochim. Biophys. Acta
(2014), http://dx.doi.org/10.1016/j.bbalip.2013.12.016.
[310] J.D. Perlmutter, J.N. Sachs, Interleaﬂet interaction and asymmetry in phase separat-
ed lipid bilayers: molecular dynamics simulations, J. Am. Chem. Soc. 133 (2011)
6563–6577, http://dx.doi.org/10.1021/ja106626r.
[311] J. Domański, S.J. Marrink, L.V. Schäfer, Transmembrane helices can induce domain
formation in crowded model membranes, Biochim. Biophys. Acta Biomembr. 1818
(2012) 984–994, http://dx.doi.org/10.1016/j.bbamem.2011.08.021.
[312] H.S. Muddana, H.H. Chiang, P.J. Butler, Tuning membrane phase separation using
nonlipid amphiphiles, Biophys. J. 102 (2012) 489–497, http://dx.doi.org/10.1016/
j.bpj.2011.12.033.
[313] L.V. Schäfer, D.H. de Jong, A. Holt, A.J. Rzepiela, A.H. de Vries, B. Poolman, et al., Lipid
packing drives the segregation of transmembrane helices into disordered lipid do-
mains in model membranes, Proc. Natl. Acad. Sci. U. S. A. 108 (2011) 1343–1348,
http://dx.doi.org/10.1073/pnas.1009362108.
[314] Z. Zhang, L. Lu, M.L. Berkowitz, Energetics of cholesterol transfer between lipid bi-
layers, J. Phys. Chem. B 112 (2008) 3807–3811, http://dx.doi.org/10.1021/
jp077735b.
[315] W.F.D. Bennett, J.L. MacCallum, M.J. Hinner, S.J. Marrink, D.P. Tieleman, Molecular
view of cholesterol ﬂip-ﬂop and chemical potential in different membrane envi-
ronments, J. Am. Chem. Soc. 131 (2009) 12714–12720, http://dx.doi.org/10.1021/
ja903529f.
[316] W.F.D. Bennett, D.P. Tieleman, Molecular simulation of rapid translocation of cho-
lesterol, diacylglycerol, and ceramide inmodel raft and nonraft membranes, J. Lipid
Res. 53 (2012) 421–429, http://dx.doi.org/10.1194/jlr.M022491.
[317] C.L. Wennberg, D. Van Der Spoel, J.S. Hub, D. van der Spoel, Large inﬂuence of cho-
lesterol on solute partitioning into lipid membranes, J. Am. Chem. Soc. 134 (2012)
5351–5361, http://dx.doi.org/10.1021/ja211929h.
[318] T. Pillot, M. Goethals, B. Vanloo, C. Talussot, R. Brasseur, J. Vandekerckhove, et al.,
Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid
peptide, J. Biol. Chem. 271 (1996) 28757–28765.
[319] B. Charloteaux, A. Lorin, J.M. Crowet, V. Stroobant, L. Lins, A. Thomas, et al., The N-
terminal 12 residue long peptide of HIV gp41 is the minimal peptide sufﬁcient to
induce signiﬁcant T-cell-like membrane destabilization in vitro, J. Mol. Biol. 359
(2006) 597–609.
[320] J. Fantini, N. Yahi, N. Garmy, Cholesterol accelerates the binding of Alzheimer's β-
amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-
dependent sterol tuning of glycolipid conformation, Front. Physiol. 4 (2013) 120,
http://dx.doi.org/10.3389/fphys.2013.00120.
[321] C. Di Scala, J.-D. Troadec, C. Lelièvre, N. Garmy, J. Fantini, H. Chahinian, Mechanism
of cholesterol-assisted oligomeric channel formation by a short Alzheimer β-
amyloid peptide, J. Neurochem. 128 (2014) 186–195, http://dx.doi.org/10.1111/
jnc.12390.
[322] F. Peypoux, J.M. Bonmatin, J. Wallach, Recent trends in the biochemistry of
surfactin, Appl. Microbiol. Biotechnol. 51 (1999) 553–563, http://dx.doi.org/10.
1007/s002530051432.
[323] R. Maget-Dana, M. Ptak, Interactions of surfactin with membrane models,
Biophys. J. 68 (1995) 1937–1943, http://dx.doi.org/10.1016/S0006-3495(95)
80370-X.
[324] C. Carrillo, J.A. Teruel, F.J. Aranda, A. Ortiz, Molecular mechanism of membrane
permeabilization by the peptide antibiotic surfactin, Biochim. Biophys. Acta
Biomembr. 1611 (2003) 91–97, http://dx.doi.org/10.1016/S0005-2736(03)
00029-4.
[325] L. Oftedal, L. Myhren, J. Jokela, G. Gausdal, K. Sivonen, S.O. Døskeland, et al., The
lipopeptide toxins anabaenolysin A and B target biological membranes in a
cholesterol-dependent manner, Biochim. Biophys. Acta 1818 (2012) 3000–3009,
http://dx.doi.org/10.1016/j.bbamem.2012.07.015.
3190 M. Deleu et al. / Biochimica et Biophysica Acta 1838 (2014) 3171–3190[326] L. D'Auria, M. Deleu, S. Dufour, M.-P. Mingeot-Leclercq, D. Tyteca, Surfactins mod-
ulate the lateral organization of ﬂuorescent membrane polar lipids: a new tool to
study drug:membrane interaction and assessment of the role of cholesterol and
drug acyl chain length, Biochim. Biophys. Acta 1828 (2013) 2064–2073, http://
dx.doi.org/10.1016/j.bbamem.2013.05.006.
[327] M. Deleu, O. Boufﬁoux, H. Razaﬁndralambo, M. Paquot, C. Hbid, P. Thonart, et al.,
Interaction of surfactin with membranes: a computational approach, Langmuir
19 (2003) 3377–3385, http://dx.doi.org/10.1021/la026543z.
[328] A. Grau, J.C. Gómez Fernández, F. Peypoux, A. Ortiz, A study on the interactions of
surfactinwith phospholipid vesicles, Biochim. Biophys. Acta 1418 (1999) 307–319.
[329] S. Buchoux, J. Lai-Kee-Him, M. Garnier, P. Tsan, F. Besson, A. Brisson, et al.,
Surfactin-triggered small vesicle formation of negatively charged membranes: a
novel membrane-lysis mechanism, Biophys. J. 95 (2008) 3840–3849, http://dx.
doi.org/10.1529/biophysj.107.128322.
[330] M. Deleu, M. Paquot, P. Jacques, P. Thonart, Y. Adriaensen, Y.F. Dufrêne, Nano-
meter scale organization of mixed surfactin/phosphatidylcholine monolayers,
Biophys. J. 77 (1999) 2304–2310, http://dx.doi.org/10.1016/S0006-3495(99)
77069-4.
[331] R. Maget-Dana, F. Peypoux, Iturins, a special class of pore-forming lipopeptides: bi-
ological and physicochemical properties, Toxicology 87 (1994) 151–174.[332] R. Maget-Dana, M. Ptak, Iturin lipopeptides: interactions ofmycosubtilin with lipids
in planar membranes and mixed monolayers, Biochim. Biophys. Acta Biomembr.
1023 (1990) 34–40, http://dx.doi.org/10.1016/0005-2736(90)90006-A.
[333] M.N. Nasir, P. Laurent, C. Flore, L. Lins, M. Ongena, M. Deleu, Analysis of calcium-
induced effects on the conformation of fengycin, Spectrochim. Acta A Mol. Biomol.
Spectrosc. 110 (2013) 450–457, http://dx.doi.org/10.1016/j.saa.2013.03.063.
[334] J. Schneider, K. Taraz, H. Budzikiewicz, M. Deleu, P. Thonart, P. Jacques, The struc-
ture of two fengycins from Bacillus subtilis S499, Z. Naturforsch. C. 54 (1999)
859–865.
[335] M. Deleu, M. Paquot, T. Nylander, Fengycin interaction with lipid monolayers at the
air-aqueous interface-implications for the effect of fengycin on biological mem-
branes, J. Colloid Interface Sci. 283 (2005) 358–365, http://dx.doi.org/10.1016/j.
jcis.2004.09.036.
[336] H. Patel, C. Tscheka, K. Edwards, G. Karlsson, H. Heerklotz, All-or-none membrane
permeabilization by fengycin-type lipopeptides from Bacillus subtilis QST713,
Biochim. Biophys. Acta 1808 (2011) 2000–2008, http://dx.doi.org/10.1016/j.
bbamem.2011.04.008.
[337] M.P. Mingeot-Leclercq, L. Lins, M. Bensliman, F. Van Bambeke, P. Van Der Smissen,
J. Peuvot, et al., Membrane destabilization induced by beta-amyloid peptide 29–42:
importance of the amino-terminus, Chem. Phys. Lipids 120 (2002) 57–74.
